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background: ICSI is currently themost commonly used assisted reproductive technology, accounting for 70–80%of the cycles performed.
This extensive use, even excessive, is partly due to the high level of standardization reached by the procedure. There are, however, some aspects
that deserve attention and can still be ameliorated. The aim of this systematic review was to evaluate the results of available publications dealing
with the management of speciﬁc situations during ICSI in order to support embryologists in trying to offer the best laboratory individualized
treatment.
methods: This systematic review is based onmaterial obtained by searching PUBMEDbetween January 1996 andMarch 2015.We included
peer-reviewed, English-language journal articles that have evaluated ICSI outcomes in the case of (i) immature oocytes, (ii) oocyte degeneration,
(iii) timing of the various phases, (iv) polar body position during injection, (v) zona-free oocytes, (vi) fertilization deﬁciency, (vii) round-headed
sperm, (viii) immotile sperm and (ix) semen samples with high DNA fragmentation.
results:More than 1770 articles were obtained, fromwhich only 90were speciﬁcally related to the issues developed for female gametes and
55 for the issues developed for male gametes. The studies selected for this reviewwere organized in order to provide a guide to overcome road-
blocks. According to these studies, the injection of rescue metaphase I oocytes should be discouraged due to poor clinical outcomes and a high
aneuploidy rates; laser-assisted ICSI represents anefﬁcientmethod to solve thehighoocytedegeneration rate; theoptimal ICSI timing and thebest
polar body position during the injection have not been clariﬁed; injected zona-free oocytes, if handled carefully, can develop up to blastocyst stage
& The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Reproduction Update, Vol.0, No.0 pp. 1–34, 2015
doi:10.1093/humupd/dmv050
 Human Reproduction Update Advance Access published November 18, 2015
 at U
niversia degli Studi di Siena on D
ecem
ber 3, 2015
http://hum
upd.oxfordjournals.org/
D
ow
nloaded from
 
and implant; efﬁcient options can be offered to patients who suffered fertilization failure in previous conventional ICSI cycles. Most controversial
and inconclusive are data on the bestmethod to select a viable spermatozoawhen only immotile spermatozoa are available for ICSI and, to date,
there is no reliable approach to completely ﬁlter out spermatozoawith fragmentedDNA from an ejaculate. However,most of the studies do not
report essential clinical outcomes, such as live birth, miscarriage and fetal abnormality rate, which are essential to establish the safety of a proced-
ure.
conclusions: This review provides the current knowledge on some controversial technical aspects of the ICSI procedures in order to
improve its efﬁcacy in speciﬁc contexts. Notwithstanding that embryologists might beneﬁt from the approaches presented herein in order to
improve ICSI outcomes, this area of expertise still demands a greater number of well-designed studies, especially in order to solve open
issues about the safety of these procedures.
Key words: ICSI / fertilization failure / sperm / oocyte activation / globozoospermia / zona-free oocyte / metaphase I oocyte
Introduction
ICSIwas introduced in theearly 1990sasoneof themostdramatic techno-
logical breakthroughs in assisted reproductive technology (ART). After its
introduction, the techniquewas rapidly incorporated into the routine clin-
ical practice of fertility centers throughout the world. Based on data from
National and Regional registersworldwide, the use of ICSI increased from
39.6% of ART cycles in 1997 to 58.9% in 2004. To date, 10s of 1000s of
childrenhavebeenborn around theworld as the result of ICSI (NyboeAn-
dersen et al., 2008). These ﬁgures suggest the trend of ICSI being used in-
creasingly also in couples without a diagnosis of severe male factor and
underlines that the procedure is practiced today as a medical adaptation
and development to the beneﬁt of the infertile couples. Indeed, the
common thought in support of ICSI efﬁciency has favored a shift toward
an increased use also for mild and borderline male factor infertility, for
unexplained infertility and women of advanced age, although evidence
supporting these indications is limited (Harper et al., 2012; Babayev
et al., 2014; Sanchez-Calabuig et al., 2014). This extensive use, even exces-
sive, is partly due to the high level of standardization and the popularity
reached by the procedure and by the tremendous increased efﬁcacy
demonstrated during recent years.
The various stepsof the conventional ICSI, fromoocyte denudation to
sperm immobilization to sperm injection into the egg, seem well estab-
lished considering the 1000s of highly trained ICSI technicians/embryol-
ogists in the world performing the procedure. This is, however, only
partially true. As a matter of fact, there are still potential weaknesses in
established ICSI protocols andwhat is common in performing microma-
nipulation procedures is the lack of attention to details other than the
mechanical aspects. Speciﬁc situations and aspects responsible for
poor performance or failure of the proceduremostly related to severely
dysfunctional gametes are only partially unraveled.
The purpose of this systematic review was to evaluate the results of
available publications dealing with the more controversial technical
aspects of various steps in human ICSI. Issues still unclear related to
methods used to limit the failure of the various steps, timing of the
various phases and procedures to circumvent severe sperm alterations
have been investigated in depth. A special attention has been paid to
aspects for which systematic reviews or meta-analysis have not already
deﬁned the more scientiﬁcally correct strategy or that unexplainably
has received only limited attention, with the ultimate aim to suggest
possible reﬁnements of the ICSI procedure to the 1000s of ICSI
technicians/embryologists and provide them with a pragmatic tool for
potential improvements of ART outcomes. Based on this analysis,
safety concerns have emerged and will be discussed.
Methods
The PRISMA statement was used for reporting the Methods, Results and Dis-
cussion sections of the current review (Moher et al., 2009). No institutional
review board approval was required because only published and de-identiﬁed
data were analyzed. The search strategy, inclusion and exclusion criteria were
speciﬁc foreachof the twomainaimsof this systematic review(issues related to
female and male gametes) and described below.
Literature search
General criteria
A systematic computerized search of the literature, from January 1996 until
March 2015, was performed in two electronic databases (PubMed and
MEDLINE) in order to identify relevant articles to be included for the
purpose of this systematic review. All pertinent articles were examined
and their reference lists were systematically reviewed in order to identify
other studies for potential inclusion in this article.
Studies were reviewed by two independent reviewers (P.R. and A.L.) and
discrepancieswere resolvedby consensus including a third author (P.V.). The
reviewers were not blinded to the names of investigators or sources of
publication. First, eligibility was assessed based on titles and abstracts.
Full manuscripts were obtained for all selected studies and decision for
ﬁnal inclusion was made after detailed examination of the papers.
Speciﬁc criteria
Two independent authors (P.R. and A.L.) run a speciﬁc literature search
for each of the two main aims of this article (Fig. 1). The search included
the combination of the following keywords and medical subjects heading
terms alone or in combination:
(i) Metaphase I, oocytedegeneration, timing, polar bodyposition, zona-free
oocyte, fertilization failure, oocyte activation, ICSI, intracytoplasmic
sperm injection.
(ii) Sperm, spermatozoa, globozoospermia, absolute asthenozoospermia,
immotile, DNA fragmentation, ICSI, intracytoplasmic sperm injection.
Selection criteria
Peer-reviewed, English-language journal articleswere included in this system-
atic review.At theﬁrst screening, titleswere investigatedand studieswith lack
of any relevance were excluded. The second screen was performed by
reading the abstract of retained publications (Fig. 1). Analyses not reporting
ICSI outcomes were excluded, as well as studies not reporting original data
including reviews, meta-analyses or comments. Full papers of all remaining
items were collected and for each study, the following information was
collected: ﬁrst author’s last name, year of publication, research objective,
design of the study, outcomes investigated and conclusions. Speciﬁcally,
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the following outcomes were extracted: fertilization and cleavage rates, Day
3 embryo quality, blastocyst development, implantation, clinical pregnancy,
abortion and live birth rates. Randomized controlled trials (RCTs), prospect-
ive cohort studies, case–control studies, retrospective cohort studies, case
series and case reports were screened where available.
ICSI and female gametes
How to manage metaphase I oocytes
Biological basis
The majority of the oocytes recovered following administration of high
doses of FSH and a high dose of human chorionic gonadotrophin
(hCG) is at the metaphase II (MII) stage and ready to be fertilized.
However, there are some that do notmature and remain in the germinal
vesicle (GV) or metaphase I (MI) stage. The maintenance of meiotic
arrest as well as meiotic resumption is the result of a highly coordinated
system between the follicle cells and the oocytes. Chromatin condensa-
tion, organelle redistribution and cytoskeletal changes are only a few
examples of the events taking place during oocyte maturation. After
the acquisitionof the capacity to resumemeiosis (namednuclear compe-
tence), the ability to be fertilized and develop further into an embryo
(named developmental competence) is also acquired during follicular
growth and after the oocyte has reached nuclear competence. Develop-
mental competence includes the relocation of ribosomes andmitochon-
dria, the reorganization of the endoplasmic reticulum (ER), the storageof
essential transcripts required during early embryo development and the
ability to modulate calcium release (Coticchio and Brambillasca, 2013;
Jones et al., 2013). On the other hand, maturation in vitro, intended as
meiotic resumption and progression to the MII stage, can be achieved.
Oocyte in vitro maturation (IVM) has been developed in order to
provide culture conditions that allow acquisition of developmental
competence encompassing nuclear competence. However, collective
evidence indicates that in vitro-matured oocytes have a reduced develop-
mental potential in comparison to their in vivo counterparts (Coticchio
et al., 2012). Thus, IVM remains an approach that few clinics currently
apply on a routine basis, needing a high clinical and technical expertise.
But apart from the clinical IVM approach, in the daily IVF laboratory prac-
tice,15%of the oocytes obtained are not at theMII stage but remain at
prophase I (10%) and MI (5%) and their potential clinical use repre-
sents a matter of debate (Cha and Chian, 1998; De Vos et al., 1999;
Schultz, 2002; Nogueira et al., 2004). The clinical application of a short-
term culture of MI oocytes in a conventional IVF program has been eval-
uatedwith controversial and confused results. It should be considered in
this context thatwhile both oocyte-derived and follicular-derived factors
regulate both meiotic arrest and resumption, the timing of meiosis I is
governed by the oocyte itself (Jones et al., 2013). Following GV break-
down, increasing activity of the cyclin-dependent protein kinase 1
(CDK1) is essential for this dynamic period of the oocyte maturation
as it promotes chromosome condensation and spindle formation.
Once homologous chromosomes are aligned on the metaphase
spindle, anaphase and meiotic exit can proceed, a process requiring a
decline in CDK1 activity which is achieved principally by degradation of
the cyclin B1. The ligase anaphase-promoting complex (APC) is critical
in this step as it favors anaphase progression by promoting the degrad-
ation of cyclin B1 to lower CDK1 activity, thus allowing homolog
separation and ultimately extrusion of the ﬁrst polar body. Another
mechanism important for completion of meiosis I implies the physical
interaction between CDK1 and separase, the protein that allows the
homologous chromosomes to be pulled to opposite poles of the
meiotic spindle. Overall, these passages highlight a very sophisticated
process thatmay reﬂect the need for large size of the oocyte. Moreover,
Figure 1 Flow diagram of the literature search: (a) search for issues related to human female gametes and (b) search for issues related to human male
gametes.
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accumulation of cytoplasmic components occurs while the oocyte is
progressing through maturation such that by time MII stage is reached,
the bulk of cytoplasmic events are completed. Thus, there are several
molecular candidates that may be perturbed during this process
causing a maturation arrest, among which spindle organization defects
or chromosomal aberrations represent the most signiﬁcant (Coticchio
and Brambillasca, 2013; Jones et al., 2013).
Interventions
Based on the biological principles of oocyte development, only mature
oocytes are injected by ICSI on a regular basis, whereas the immature
oocytes are usually discarded. However, the use of immature oocytes
could increase the number of embryos available. This issue is differently
managed in the various clinical laboratories, but the possibility to use the
MIoocytes in the daily practicemight represent an advantage.Moreover,
this topic has received a renewed interest from the diffusion of the pre-
implantation genetic screening. From1999, 10papers haveevaluated the
clinical outcomes derived from short-term (,8 h) in vitro cultured MI
oocytes thatprogressed toMII oocytes (Table I). Sevenare retrospective
(De Vos et al., 1999; Huang et al., 1999; Balakier et al., 2004; Vanhoutte
et al., 2005; Shu et al., 2007; De Vincentiis et al., 2013; Shin et al., 2013),
one is a prospective cohort study (Strassburger et al., 2010) and two
have randomized the oocyte treatment according to time of culture
(Strassburger et al., 2004; Li et al., 2011). All the studies have used the
same culture medium for both mature and immature oocytes. Fertiliza-
tion rate was shown to be signiﬁcantly reduced for in vitro rescued
MI oocytes compared with MII oocytes in eight studies (De Vos et al.,
1999; Huang et al., 1999; Balakier et al., 2004; Strassburger et al.,
2004; Vanhoutte et al., 2005; Strassburger et al., 2010; De Vincentiis
et al., 2013; Shin et al., 2013), while no signiﬁcant difference was found
in two studies (Shu et al., 2007; Li et al., 2011). Interestingly, in ﬁve
studies, fertilization rate of rescued oocytes was higher than 60%
(Huang et al., 1999; Shu et al., 2007; Strassburger et al., 2010; Li et al.,
2011; De Vincentiis et al., 2013). Cleavage rate was signiﬁcantly
reduced for in vitro-matured oocytes in two studies (Balakier et al.,
2004; Strassburger et al., 2004), not different in four studies (De Vos
et al., 1999; Huang et al., 1999; Shu et al., 2007; Li et al., 2011) and not
evaluated in the others (Vanhoutte et al., 2005; Strassburger et al.,
2010; De Vincentiis et al., 2013; Shin et al., 2013). Unfortunately, most
of the studies failed to document embryo transfer procedures derived
from MI–II-derived embryos only. This was probably due to the fact
that transfers were mostly performed mixing embryos derived from
both mature and rescued oocytes or rather there was a tendency to
avoid the transfer of MI–II-derived embryos. However, the two studies
that reported the highest number of embryo transfers from rescued MI
oocytes (n ¼ 15 and 10) (De Vos et al., 1999; De Vincentiis et al., 2013)
showedaclinical pregnancy rateof6.6 and10%.Overall, 33embryo trans-
fer procedures from short-term in vitro-matured oocytes have been
reported and 4 clinical pregnancies derived, 2 ending in abortion.
Thepaper by Shin et al. (2013) reported the outcomeof 24 ICSI cycles
with no mature oocytes at oocyte denudation. Thirty-six MI oocytes
matured to MII stage after in vitro culture of 3–4 h. The fertilization
rate of this group of oocytes was 37% and ﬁve transfer procedures
were performedwith no clinical pregnancies. Importantly, the prospect-
ive study by Strassburger et al. (2010) has examined the fate and the
chromosomal status of embryos achieved from immature oocytes
arrested or rescued after various periods of in vitro culture. Embryo
euploidy was evaluated by ﬂuorescence in situ hybridization using
probes for chromosomes X,Y and 18. In general, a high proportion
(80.6%) of embryos from MI oocytes was genetically abnormal.
However, whereas the aneuploidy rate was 100% for MI oocytes
rescued after 24 h of incubation, this rate was reduced to 66.6% when
oocytes were rescued after 4–8 h and to 40% after a short incubation
period (2 h) and this latter ﬁgure was similar to the rate of abnormal
embryos (40.3%) routinely found in the authors’ PGD program
(Strassburger et al., 2010).
Based on the available publications, thewidespread use of MI oocytes
cannot be recommended.
The poor clinical outcomes and the generally higher aneuploidy rates
would suggest that an additional patient counseling is advisable in case
no mature oocytes are available, in order to discuss the potential risk of
transferring embryos derived from MI oocytes. Aneuploidy screening
would be useful in this regard. Although the use of immature oocyte
could increase the number of embryos available to ensure the embryo
transfer, the safetyof patients and fetus should always represent a priority.
How to manage oocyte degeneration
Oocyte degeneration is a common phenomenon experienced by
all technicians performing ICSI, ranging from 5 to 19% (Palermo
et al., 1992, 1996; Van Steirteghem et al., 1993; Nagy et al., 1995;
Ebner et al., 2001; Yavas et al., 2001). The degeneration can be
observed immediately after withdrawal of the injection needle, coex-
isting with sudden breakage upon needle entry and leakage of cyto-
plasm. However, the degeneration may also follow normal injection,
being identiﬁed the following day by a retracted and/or darkened
ooplasm (Rosen et al., 2006).
Biological basis
Limited investigation has addressed the causes of oocyte degeneration.
Degeneration has been suggested to be dependent on the inherent
oocyte quality in women undergoing ovarian stimulation and possibly
related to the stimulation itself. Day 3 FSH levels, number of mature
oocytes retrieved and estradiol levels on the day of hCG triggering
have been shown to be signiﬁcant independent predictors of degener-
ation rate (Rosen et al., 2006). Sudden breakage of the oolemma
(Nagy et al., 1995; Palermo et al., 1996), absence of persistence of
funnel after the withdrawal of the injection pipette (Ebner et al., 2003)
and difﬁcult breakage of the oolemma (Ebner et al., 2001) have been
reported as events possibly favoring oocyte degeneration during ICSI
related to an intrinsic poor oocyte quality.
Although the injection technique requires experience by the labora-
tory technician and implies a learning curve, therearenopublications sus-
taining the idea that oocyte degeneration rate may be a function of
technician skills. In a prospective study on sibling oocytes, blastocyst de-
velopment rate of surplus embryoswas found to be signiﬁcantly different
among four ICSI technicians according to the volume of cytoplasm aspi-
rated by each of them during the procedure. When .6 pl of cytoplasm
was aspirated into the injection pipette, the development to the blasto-
cyst stage was found to be compromised. Nevertheless, the degener-
ation seemed to be independent from the volume of cytoplasm
aspirated (Dumoulin et al., 2001). In line, in a prospective study regarding
the inﬂuence of the polar body position during the injection, a difference
between two operators in terms of fertilization rates was observed,
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Table I Summaryof the 10papers identiﬁed in a systematic reviewof the literature inorder to investigate the approaches used tomanage themetaphase I oocytes
in human ICSI cycles.
Oocytes (n) FR (%) CR (%) Good EQ
rate (%)
Embryo
transfer (n)
CPR Incubation
time
Culture medium P/PR/R
study
Huang et al. (1999) 239 (720) 62 (81)
P, 0.001
90 (94)
NS
58 (87)
P, 0.001
— — ,8 h M2 (Medicult) R
De Vos et al. (1999) 1210 (8803) 52.7 (70.8)
P, 0.001
82.5 (83.4)
NS
53.4 (59.8)
P, 0.01
15 6.6% 4 h B2 (SIGMA) R
Strassburger et al. (2004) 116 (4668) 44 (68)
P, 0.01
86 (95)
P, 0.01
2.0 (1.9)a
NS
1 One clinical pregnancy
reportedb
,4 h G1.2 (Vitrolife) PR
Vanhoutte et al. (2005) 117 (339) 48.7 (68)
P, 0.001
— 40.3 (30.6)
NS
— — 2–7 h Fertil medium (COOK)
Early cleavage medium
(Irvine Scientiﬁc)
R
Shu et al. (2007) 259 (1740) 62.2 (69.5)
NS
98.8 (99.4)
NS
49.7 (68.2)
P, 0.01
— — ,4–6 h Cleavage medium
(SAGE) + SSS (Irvine)
R
Balakier et al. (2004) 468 (3293) 42 (77)
P, 0.0001
53 (74)
P, 0.0001
55 (61)
NS
4 0 ,3 h IVC-one medium
(In vitro Care)
+ SSS (Somagen)
R
Strassburger et al. (2010) 96 (2500) 61.4 (71.5)
P, 0.05
96.6 (—) 2.4–2.6a
(—)
— — ,4–8 h G1.2 + HSA (Vitrolife) P
Li et al. (2011) 51 (1674) 68.6 (74.5)
NS
91.4 (90.5)
NS
51.4 (59.4)
NS
3 Twin ongoing
pregnancy reportedb
3–5 h G-IVF (Vitrolife) PR
De Vincentiis et al. (2013) 669 (3044) 65.2 (76.1)
P, 0.0001
— — 10 (306) 10% ,2–5 h Early cleavage
medium + HSA (Irvine)
R
Shin et al. (2013) 775 (3482) 37 (72.3)
P, 0.05
— — — — ,3–4 h IVF (GIII series) (Vitrolife) R
Numbers in parentheses refer to corresponding ﬁgures for control MII mature oocytes.
MII, metaphase II; CR, cleavage rate; FR, fertilization rate; EQ, embryo quality; CPR, clinical pregnancy rate; P, prospective; PR, prospective randomized; R, retrospective; HSA, human serum albumin; SSS, serum supplement substitute, NS, not
signiﬁcant.
aMorphology score.
bEnded in abortion.
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whereas no signiﬁcant differenceswere foundwith regard to the number
of degenerated oocytes (Van der Westerlaken et al., 1999).
On the other hand, degeneration of oocytes seems closely related to
certain unexpected random technical problems. Among these, the ex-
cessivemanipulation inside theoocytedue to the spermatozoon remain-
ing attached to the injection pipette at the moment of deposition, or the
inadvertent oolemmadamage at the opposite site of the injection hole as
a result of a too deep penetration by the injection pipette. Another crit-
ical issue is represented by the oocyte deformation during the various
steps for the possible damage to the cytoskeleton. If the diameter of
the cumulus-removal pipette is too small, then oocytes can be very
strongly compressed when aspirated into the pipette, possibly favoring
the leaking away of the cytoplasm after injection, resulting in degener-
ation (Nagy et al., 1995).
The mechanical removal of cumulus and corona cells may also play a
role in the etiology of oocyte degeneration and of the sudden breakage
of oolemma during ICSI. Interestingly, in two different publications,
Ebner et al. (2001, 2006) reported that an incomplete oocyte denuda-
tion, while allowing to improve Day 2 and 3 embryo morphology as
well as blastocyst formation, also produced a signiﬁcantly higher degen-
eration rate. In this case, the residual surrounding somatic cells may
hinder optimal injection and, consequently, be the cause of an increased
damage rate or, alternatively, some hydraulic ﬁxation problems on the
holding pipettemayoccur, resulting in a highly invasive injection process.
Interventions
In 2009, Evison et al. reported a signiﬁcant decrement of oocyte damage
when they switched from a traditional bovine-derived hyaluronidase to
the recombinant human hyaluronidase for the removal of cumulus–
corona–oocyte complex before ICSI (Evison et al., 2009). The study
had however some important limitations, including its retrospective
nature. Moreover, the equipment used for ICSI was updated during
the study, probably contributing to the improvement observed.
When the zona pellucida is hard and/or the injection pipette is rela-
tively large and/or blunt, then the oocyte is compressed into a ﬁgure
of eight shape before the microinjection pipette can penetrate the
zona pellucida (Fig. 2), possibly causing oocyte degeneration (Ebner
et al., 2001). In line with this observation, in a retrospective study,
Yavas et al. (2001) reported a signiﬁcant decrease in the degeneration in-
cidence after ICSI using injection pipette with a smaller inner diameter
and a longer taper: 3–5 mm inner diameter (which is the smallest pos-
sible inner diameter according to thewidth of the normal spermatozoon
head) instead of 5–7 mm. The positive effect of a thinner injection
pipette was explained with at least three beneﬁts: minimized degree of
mechanical trauma exerted on the oolemma, minimized amount of
ooplasm aspirated into the injection pipette prior to injection, and mini-
mized amount of PVP (polyvinylpyrrolidone) injected into the oocyte
along with the spermatozoon (Yavas et al., 2001; Table II).
In order to minimize the oocyte deformation related to the difﬁculty of
passing the zona pellucida, a new approach, the laser-mediated ICSI, was
described in early 2000s. This technique allows to perform a micro-hole
(diameter 5–10 mm) in the zona pellucida by a laser beam just prior to
ICSI and the injection pipette is introduced through the hole permitting
penetration of the micro-needle without any trauma. The ﬁrst evidence
of the efﬁcacy of this technique was published in two distinct case reports
(Rienzi et al., 2001; Nagy et al., 2002). Both described a clinical pregnancy
obtained in cases with repeated ICSI failure due to oocyte degeneration
(Table II). Afterwards, three prospective studies on sibling oocytes were
published (Abdelmassih et al., 2002; Rienzi et al., 2004; Demirol et al.,
2006). Rienzi et al. included patients with at least six MII oocytes in
whom the ﬁrst three oocytes subjected to ICSI showed a sudden
oolemma breakage reaction, while Abdelmassih et al. (2002) and
Demirol et al. (2006) included patients with one or more previous ICSI
cycles with a high degeneration rate (.20%). All three groups agreed
that a signiﬁcantly lower degeneration rate could be observed in the
groupofoocytes treatedby laser-assisted ICSI comparedwithconventional
ICSI. A signiﬁcantly higher fertilization rate and a signiﬁcantly higher embryo
quality onDay 3were reported after laser-assisted ICSI, thus leading to the
idea that the technique may decrease also damage to subcellular compo-
nents of oocytes that could affect embryo development (Table II).
The impossibility of localizing the laser-generated hole at a later
developmental stage represents the major concern in the matter of laser-
mediated ICSI (Abdelmassih et al., 2002). The small hole created in the
zona pellucida may be associated with a certain risk of embryo trapping
leading to degeneration of the blastocyst if it cannot escape from the
outer shell, or ofmonozygotic twinning if the emerging embryo is restricted
and subsequent splitting occurs (Mantoudis et al., 2001). Although no cases
of monozygotic twinning have been reported for laser-assisted ICSI, Moser
et al. described a different approach to laser-assisted ICSI in a prospective
study on sibling oocytes of unselected population. The zona pellucida was
simply thinnedandnotopenedbymeansof laser immediatelyprior to injec-
tion. They reported a signiﬁcantly lower degeneration rate in the study
group, a better embryoquality onDay 2 and an increased clinical pregnancy
rate followingDay3embryo transfer.An increasedherniationofDay5blas-
tocysts was also described (Moser et al., 2004).
More recently, in a prospective randomized study in a general patient
population,Choietal. (2011)observedhigher fertilization, andhigherblas-
tulation and clinical pregnancy rates in the laser-assisted thinning ICSI
group compared with the conventional ICSI group (Choi et al., 2011).
However, not all the studies agree on the positive effects of laser ICSI. In
a prospective study on sibling oocytes, Richter et al. (2006) observed
that the use of laser-assisted ICSI in unselected patients does not have
any beneﬁcial effect in terms of oocyte fertilization, degeneration rate,
Figure 2 Oocyte deformation related to the difﬁculty of passing the
zona pellucida (200× magniﬁcation).
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Table II Summaryof the10papers identiﬁed ina systematic reviewof the literature inorder to investigate theapproachesused toreduceoocytedegenerationrate
after ICSI.
Issue Approach Indications DR FR Good EQ
rate
BL rate CPR IR AbR P/PR/R/
CR study
Yavas et al. (2001) Oocyte
injection
Injection pipette with
ID of 3–5 mm
Non-selected population Decreased Improved Improved — — — — R
Rienzi et al. (2001) Oocyte
injection
Laser-assisted ICSI High DR after ICSI Decreased — — — One clinical
pregnancy reported
— — CR
Nagy et al. (2002) Oocyte
injection
Laser-assisted ICSI High DR after ICSI Decreased — — — One twin clinical
pregnancy reported
— — CR
Abdelmassih et al.
(2002)
Oocyte
injection
Laser-assisted ICSI High DR after ICSI Decreased Unchanged Improved — — — — PR
Moser et al.
(2004)
Oocyte
injection
Laser-assisted ZT
before ICSI
Non-selected population Decreased Unchanged Improved Unchanged Improveda — — PR
Rienzi et al. (2004) Oocyte
injection
Laser-assisted ICSI Oocyte with sudden
oolemma breakage
Decreased Unchanged Unchanged — — — — P
Demirol et al.
(2006)
Oocyte
injection
Laser-assisted ICSI Recurrent ICSI failure with
limited MII oocytes
Decreased Improved Improved — — — — PR
Richter et al.
(2006)
Oocyte
injection
Laser-assisted ICSI Non-selected population Unchanged Unchanged Unchanged Unchanged — — — PR
Evison et al.
(2009)
Oocyte
denudation
Recombinant
hyaluronidase
Non-selected population Decreased Improved — — — — — R
Choi et al. (2011) Oocyte
injection
Laser-assisted ZT
before ICSI
Non-selected population Unchanged Improved — Improved Improved Unchanged — PR
Improved or decreased results are indicated only when statistically signiﬁcant.
ID, inner diameter; ZT, zona thinning; DR, degeneration rate; BL, blastocyst formation; IR, implantation rate; AbR, abortion rate; CR, case report.
aExclusive transfer of the study embryos on Day 3 resulted in a signiﬁcantly better pregnancy rate.
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embryo cell numbers and fragmentation rate onDay 2 and 3, as well as in
terms of compaction and blastocyst formation rate (Richter et al., 2006)
(Table II). It is however reasonable to consider the laser-assisted ICSI as
an efﬁcient and easy approach to prevent oocyte damage in patients
with a history of high oocyte degeneration rate in previous ICSI cycles or
for oocytes with a sudden breakage feature.
How to manage choice of ICSI timing
Biological basis
Nuclear maturity can easily be assessed before ICSI as it is evidenced by
the expulsion of the ﬁrst polar body. However, the complete oocyte
maturation does not only depend on nuclear meiotic progression and
DNA remodeling. Cytoplasmic maturity process is thought to involve
the synthesis of variousmaternal mRNAs and proteins with very speciﬁc
and precise mechanisms, reorganization of the cytoplasmic organelles in
the cytoskeleton and acquirement of a full complement of Ca2+ signaling
molecules (Coticchio et al., 2015).
For normal fertilization to occur, both nuclear and cytoplasmic
maturity are required independently.
In natural cycles, nuclear and cytoplasmic maturity are highly coordi-
nated, whereas in stimulated cycles, the two phenomena appear to be
asynchronous (Sundstrom andNilsson, 1988; Eppig et al., 1994; Balakier
et al., 2004); therefore, pre-incubation of oocytes prior to IVF or ICSI
may favor the cytoplasmic maturation that could eventually increase fer-
tilization and also pregnancy rates. According to this idea, evidence has
been provided indicating that human oocytes progressively develop
the ability for normal activation and development during the MII arrest
stage (Balakier et al., 2004). On the other hand, when arrested at MII
stage, if not fertilized in time, the ovulated oocytes undergo a time-
dependent process of aging that can result in a signiﬁcant decrease in em-
bryonic development and pregnancy rate following in vitro procedures
(Miao et al., 2009). Moreover, contrary to in vivo-matured oocytes, the
in vitro-matured oocytes stay in contact with their cumulus cells until ar-
tiﬁcially removed. If it is true that the surrounding cumulus cells have a
role in oocyte maturation, ovulation and fertilization (Tanghe et al.,
2002), based on mouse models, cumulus cells seem to accelerate the
aging process of oocytes in away that increaseswith the density and dur-
ation of culture (Miao et al., 2009). A signiﬁcant culture time-dependent
increase in the apoptotic rates of cumulus cells has been recently
described, which is associated with the apoptotic cumulus cell release
of a soluble FAS ligand interacting with FAS on oocytes and mediating
oocyte aging (Zhu et al., 2015). For all these reasons, ICSI timing repre-
sents a critical aspect of the overall procedure.
Although it has been shown that incubation of oocytes for 2–6 h prior
to IVF improves fertilization and pregnancy rates (Trounson et al., 1982;
Harrison et al., 1988; Veeck, 1988; Khan et al., 1989), the results regarding
the timing of ICSI are still conﬂicting, probably owing to the retrospective
design of the studies and the different strategies proposed (Table III).
Given the conceptually very different approach used by those that exam-
ined the pre-incubation period effect in the presence and absence of
cumulus–corona cells, this part will be divided according to this aspect.
Interventions
Pre-incubation of oocytes with cumulus–corona cells before denudation and
ICSI. Various authors examined the effects of different pre-incubation
times in ICSI cycles in which the oocyte denudation was performed
just before the injection of sperm (Rienzi et al., 1998; Yanagida et al.,
1998; Hassan, 2001; Ho et al., 2003; Isiklar et al., 2004; Aletebi, 2011).
Hence, the oocytes were incubated in vitro with their cumulus and
corona cells. With the ovum retrieval performed at 35 h after hCG ad-
ministration, Yanagida et al. (1998) did not ﬁnd any statistical difference
in survival, fertilization, cleavage and pregnancy rateswhenoocyteswere
cultured between 1 and 11 h before ICSI, with 3 h time intervals.
At 9–11 h of pre-incubation time, the proportion of good-quality
embryos was signiﬁcantly lower (Yanagida et al., 1998). In contrast,
others consistently found a beneﬁcial effect of a pre-incubation time
≥2–3 h on the fertilization rate (Rienzi et al., 1998; Hassan, 2001; Ho
et al., 2003; Isiklar et al., 2004; Aletebi, 2011; Table III). Three groups
reported also a higher good-quality embryo rate, and Aletebi (2011)
even a signiﬁcantly higher clinical pregnancy rate when a pre-incubation
time of ≥2–3 h was applied. The optimal time range after oocyte re-
trieval for a more successful ICSI varied from 2 h according to Aletebi
(2011) to 3–12 h for Rienzi et al. (1998). The ovum retrieval was per-
formed at 36 h from hCG administration in all these studies except for
the study by Ho et al. (2003) who performed the ovum retrieval at 35 h.
Pre-incubation of oocytes without cumulus–corona cells before ICSI. Two
retrospective studies have examined the effects of different pre-
incubation times without the cumulus–corona cells surrounding the
oocytes in ICSI cycles, reporting that a limited pre-incubation time has
no effect on outcomes (Andrews et al., 2001; Falcone et al., 2008;
Table III). Hence, in the two studies, cumulus and corona cells were
removed within 1 h from oocyte retrieval (Andrews et al., 2001) and
after 2 h (Falcone et al., 2008). Pre-incubation times without cumulus–
corona cells from 2 to 6 h did not compromise outcomes parameters,
while a longer period (.5 h) had negative effects on fertilization,
cleavage and pregnancy rates. In both studies, the ovum retrieval was
performed at 36 h from hCG administration.
Pre-incubation of oocytes with or without cumulus–corona cells before ICSI.
The only two prospective studies focusing on the inﬂuence of a pre-
incubation timewith orwithout cumulus–corona cells showedopposite
results (Table III). Van de Velde et al. (1998) did not ﬁnd any statistical
difference in terms of survival, fertilization and embryo cleavage rates
between early (1–2 h after retrieval) and late (5–6 h after retrieval)
injection, both when oocytes were pre-incubated with and without
cumulus–corona cells. The oocyte retrieval was performed at 36 h
from hCG administration (Van de Velde et al., 1998). In contrast,
Patrat et al. (2012) reported signiﬁcant improvements in the fertilization
rates when the denudation timing was delayed (optimal results at 3 h),
while fertilization rate signiﬁcantly decreased increasing the time
between oocyte denudation and microinjection.
Among the many variables considered in the papers, time of hCG ad-
ministration may vary from 35 to 36 h before ovum retrieval. Therefore,
the different time lapses between retrieval and ICSI may have different
effect depending on this period. Dozortsev et al. (2004) have described
for the ﬁrst time the ICSI timing in terms of time interval between hCG
administration and ICSI and reported that implantation and ongoing im-
plantation rates reached the highest level when ICSI was performed
between 37 and 39 h after hCG administration, showing for the ﬁrst
time that human oocytes have a relatively narrow optimal insemination
window, as happens in mice. Finally, in a recent retrospective cohort
study, Garor et al. (2015) have evaluated the effect of manipulating
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Table III Summary of the 13 papers identiﬁed in a systematic review of the literature in order to investigate the effectiveness of various pre-incubation times of
oocytes before ICSI on embryo development and clinical outcomes.
Incubation
with/without
cumulus (1/0)
Optimal
hCG–OPU
interval
Optimal
OPU–ICSI
interval
Optimal
hCG–ICSI
interval
Optimal OPU–
denudation
interval
Optimal
denudation–
ICSI interval
Proportion
of MII
oocytes
FR Good
EQ rate
BL
rate
CPR IR AbR P/PR/R
study
Yanagida et al.
(1998)
1 — 1–9 — — — Unchanged Unchanged Improved — Unchanged Unchanged — R
Rienzi et al.
(1998)
1 — 3–12 h — — — Improved Improved — Unchanged Unchanged — R
Van de Velde
et al. (1998)
1 + 0 — — — None None Unchanged Unchanged Unchanged — — — — PR
Hassan (2001) 1 + 0 — — — 4 h 0 h Improved Improved Improved Improved Nv Nv — PR
Jacobs et al.
(2001)
1 — None — — — — Unchanged Unchanged — Unchanged Unchanged Unchanged R
Andrews et al.
(2001)
0 — ,5 h — — — — Unchanged Unchanged — — Improved — R
Ho et al.
(2003)
1 — 2.5–5.5 h — — — Improved Improved Unchanged — Unchanged — — R
Isiklar et al.
(2004)
1 — — — 2–4 h — Improved Improved Improved — Unchanged Unchanged — R
Dozortsev
et al. (2004)
— — — 37–39 h — — — Improved Unchanged — Improved Improved Unchanged R
Falcone et al.
(2008)
0 — 5–6 h — — — Improved Improved — Improved — — R
Aletebi (2011) 1 + 0 — — — 1–2 h 1–2 h Improved Improved — — Improved — — P
Patrat et al.
(2012)
1 + 0 — — — 2–3 h 0 h Unchanged Improved Unchanged — Unchanged Improved — R
Garor et al.
(2015)
1 + 0 .36 h None None Unchanged Unchanged Unchanged Improved Unchanged — Improved — — R
Improved or decreased results are indicated only when statistically signiﬁcant. OPU, oocyte pick up.
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oocyte denudation and injection timing in relation to hCG–ovum re-
trieval interval. Considering hCG–ovum retrieval intervals of more/
less than 36 h, ovum retrieval–denudation intervals of more/less than
2 h and denudation–ICSI intervals of more/less than 1 h, it was shown
that late ovum retrieval (.36 h) was associated with more available
embryos, signiﬁcantly higher fertilization and clinical pregnancy rates
than early ovum retrieval (,36 h). Conversely, the length of incubation
before or after denudation had no effect, regardless of ovum retrieval
timing (Garor et al., 2015).
In conclusion, the optimal ICSI timing is still unclear and the existing
results are not fully conclusive (Table III). Most articles are concordant
that a pre-incubation time before ICSI is beneﬁcial on ICSI results, and
cumulus–coronacellsmayhave apositive effectduring this pre-incubation.
However, the data regarding the extension of the pre-incubation time are
not concordant.
How to manage sperm and polar body
position during injection
Biological basis
The oocytes provide almost the totality of the cytoplasmic determinants
andmembranes required for the formation and development of the pre-
implantation embryo. An extreme asymmetric cytokinesis ensures the
retention of these vital maternal stores. Indeed, the sequential emission
of two polar bodies, whose sole purpose is to house the chromosomes,
ensures the formation of a genetically competent gamete with minimal
loss of cytoplasmic mass (Gitlin et al., 2003). From a microtubule
network with low dynamics during prophase arrest, the oocyte has to
form the meiotic spindle, a structure built of mostly highly dynamic
microtubules. The spindle must orchestrate the alignment and proper
segregation of homologous chromosomes and sister chromatids in the
two subsequent meiotic divisions. It forms in the center of the cell with
no connection to the cortex and no constraint on its long axis, which
takes a random orientation. After entry into meiosis I, the spindle
always migrates toward the closest cortex and the ﬁrst polar body is
extruded at anaphase I while the spindle keeps moving, imposing a
dynamic deﬁnition of the cleavage plan (Brunet and Verlhac, 2011;
Chaigne et al., 2012; Li, 2013). A prominent actin cap forms at the
cortex overlying the spindle at the site of polar body extrusion upon
anaphase I onset. In meiosis II, this cap seems to promote anchoring of
the spindle parallel to the oocyte cortex via activation of an actin ﬂow
until fertilization triggers the emission of the second polar body (Longo
and Chen, 1984; Maro et al., 1986; Deng et al., 2007; Azoury et al.,
2009; Larson et al., 2010;Maddox et al., 2012;Yi andLi, 2012).Thus, the-
oretically, the spindle should reform with the chromosomes aligned on
the MII plate, directly below the ﬁrst polar body. Historically, since the
introduction of ICSI on human oocytes, it has been assumed that the
second meiotic MII spindle lies in close proximity to the ﬁrst polar body.
This assumptionhas led to theacceptedpracticeof injecting the spermato-
zoon headﬁrst at the 3 o’ clock position, with the polar body at the 12 or
6 o’ clock position, in order to avoid damage to the MII spindle. Interest-
ingly, it has been published that the direction (headﬁrst or tailﬁrst) of the
sperm exit from the injection pipette during ICSI would not inﬂuence
the fertilization and good-quality embryo rate (Woodward et al., 2008),
while possible consequences of inserting the ICSI needle into or close to
the MII spindle have been suggested to include partial or total disruption
of the spindle or displacement of the spindle from the oolemmawith con-
sequent perturbation of chromosomal segregation and subsequent aneu-
ploidy or even cell death. However, when the injection needle is entering
theoocytes at the3o’clockposition, theopeningof thebevelof theneedle
is facing the 6 o’clock position. During the aspiration of the cytoplasm, dif-
ferent structures may be damaged or lost and it might be different if the
oocytes are injected with the polar body at the 6 o’clock or 12 o’ clock
position, since oocyte chromosomes lie near the ﬁrst polar body (Fig. 3).
Interventions
Few publications examined the optimal polar body orientation during
ICSI with quite discordant results (Table IV). Two prospective studies
reported better results when the injection was performed with polar
bodies at 6 o’clock position compared with 12 o’clock position (Van Der
Westerlaken et al., 1999; Stoddart and Fleming, 2000). Of these, Stoddart
andFleming (2000) reporteda lowerproportionof poorest gradeembryos
for the injection with polar body at 6 o’clock position but underlined that
clinical results were not inﬂuenced by the position of the polar body
during ICSI. Van derWesterlaken et al. (1999) reported higher fertilization
and pregnancy rates for the injectionwith polar body at 6 o’clock position,
although based on logistic regression analysis, a confounding factor based
on intra-individual differences was present. These results were justiﬁed
Figure3 The injection pipette is inserted from the 3o’clock position, thatmeans that theopening is always facing down toward the 6o’clock position. (a)
The polar body is in the 12 o’clock position so that the cytoplasm is aspirated froma zona situated far from themeiotic spindle. (b) The polar body is in the 6
o’clock position so that the cytoplasm is aspirated from a zona situated near the meiotic spindle (400× magniﬁcation).
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by the shorter distance between the sperm and the spindle that could
be obtained with the 6 o’ clock polar body orientation and the injection
pipette facing downward 6 o’clock, suggesting a certain polarization of
oocyte structure in such a way that fertilization and cleavage would be
facilitated when the spermatozoon is deposited closer to the spindle.
While Dumoulin et al. (2001) did not ﬁnd any differences in terms of
fertilization rate and embryo quality between 12 or 6 o’clock polar body
orientation, in the sameperiod, Blake et al. (2000) investigated in a retro-
spective manner all possible polar body orientations in order to ﬁnd the
‘ideal’ area within the oocyte to deposit the sperm. They found a signiﬁ-
cantly higher quality embryo in the 7 and 11 o’clock orientation groups
compared with the 6 and 12 o’clock orientation groups, whereas the
9 o’clock orientation was the most deleterious in terms of fertilization
rate (Blake et al., 2000). A single RCT was performed by Anifandis
et al. (2010) in which the polar body orientation at 11 o’ clock during
ICSI resulted in higher fertilization, embryo quality and clinical pregnancy
rate compared with other orientations (6, 7, 11 and 12 o’clock). The
shorter distance between sperm and the meiotic spindle that can be
obtained with 7 and/or 11 o’ clock polar body orientation compared
with 6 and 12 o’ clock orientations has been claimed as the potential
explanation for these results (Anifandis et al., 2010).
We herein also mention the retrospective study on 1545 oocytes by
Yanaihara et al. (2006) that showed thatwhen the spermatozoa remained
near the injection site after ICSI, the fertilization rate was signiﬁcantly
lower, although the embryo quality was not affected. Once again, the
better results in terms of fertilization rate obtained when injected sperm-
atozoa remained in the center or in the left of the oocytes have been
explained by the smaller distance between the sperm and the meiotic
spindle (Yanaihara et al., 2006).
When spindle imaging by polarizationmicroscopy became available in
IVF laboratories, it seemed that this technique would have been the
answer to the questions about ICSI and spindle damage, making the pre-
vious studies obsolete. It was immediately clear that the MII spindle may
not always be located directly below the ﬁrst polar body and the spindle
could be displaced from the polar body position by more than 908
(Hardarson et al., 2000; Rienzi et al., 2003). Manipulation and stress
caused during oocyte denudation are thought to represent the main
factors responsible for the spindle deviation but also intrinsic factors,
such as oocyte ageing, as in the mouse (Eichenlaub-Ritter et al., 1986;
Taylor et al., 2008), may also play a role in polar body displacement.
The displacement of the spindle away from the polar body could make
the spindle and the cytoplasm more susceptible to disturbances
caused by the ICSI needle by causing an alteration of the position of
the polarized molecules in the cytoplasm and, consequently, the
courseof embryodevelopment (Garello et al., 1999;Cookeet al., 2003).
The possibility to visualize themeiotic spindle in oocytes has been the
object of several contributions. This topic is beyond the purpose of our
paper and a meta-analysis tends to suggest that spindle presence inves-
tigation may be useful in selecting gametes with a higher chance of fertil-
ization, higher cleavage rate, Day 3 top quality embryo and blastocyst
formation rate, though no improvements in implantation and clinical
pregnancy rate per transferwere reported (Petersen et al., 2009).More-
over, studies that have investigated the relationship between themeiotic
spindle location with regard to polar body position have demonstrated
that displacements that exceed 908 are very rare (4.5%; Rienzi et al.,
2003), so that by choosing an injection angle of 908 (corresponding to
3 o’clock position), it is still theoretically possible to disturb the spindle
apparatus, but this is highly unlikely.
However, we must comment that, nowadays, the polarization
microscopy is not widely available in IVF laboratories and the optimal
polar body or spindle position during ICSI remains unclear. Differences
in the technical procedure, such as the amount of cytoplasm sucked
into the injection pipette or the force with which the injection pipette
is pushed through the oocytemembrane, may explain the poor scientiﬁc
consistency on this topic.
How to manage zona-free oocyte injection
During thedenudation procedure, the zona pellucida occasionally can be
damaged, resulting in the partial or total extrusion of the ooplasm out of
the zona pellucida.
.............................................................................................................................................................................................
Table IV Summary of the ﬁve papers identiﬁed in a systematic review of the literature in order to investigate the effect of
position of the polar body during ICSI on embryo development and clinical outcomes.
Polar
body
position
DR FR Good EQ rate BL rate CPR IR AbR P/PR/R
Van der
Westerlaken
et al. (1999)
6 and
12 o’clock
— Improved for
6 o’clock position
Unchanged — Improved for
6 o’clock
positiona
— Unchanged PR
Blake et al.
(2000)
1, 5, 6, 7, 8,
9, 10, 11,
12 o’clock
— Unchanged Improved for 7 and
11 o’clock position
— — Unchanged — R
Stoddart and
Fleming (2000)
6 and
12 o’clock
Unchanged Unchanged Unchanged — Unchanged Unchanged — PR
Dumoulin et al.
(2001)
6 and
12 o’clock
Unchanged Unchanged Unchanged Unchanged — — —
Anifandis et al.
(2010)
6, 7, 11,
12 o’clock
— Improved for
11o’clockposition
Improved for
11 o’clock position
— Unchanged — — PR
Improved or decreased results are indicated only when statistically signiﬁcant.
aThis difference was the result of signiﬁcant interaction between polar body position and the operator (see the text).
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Biological basis
The zona pellucida plays an important, protective role during fertilization
and early embryonic development. It prevents cross-species and
polyspermic fertilization and ensuresmaximum contact between blasto-
meres before the compaction occurs. Indeed, early embryos that cleave
inside the zona pellucida have blastomeres that are loosely attached to
each other and can easily be dissociated. During compaction, tight junc-
tions develop between outside cells of the embryo, sealing off the inside
of the sphere and forming a compact morula. At this stage, even zona-
free embryos may survive the transfer procedure (Vajta et al., 2010). In
most ART centers, eggs with damaged zona pellucida are generally dis-
carded. However, especially when few oocytes are retrieved, it is im-
perative to fully utilize the developmental potential of each harvested
egg to avoid the physical and psychological burden of cycle cancellation
for the individual patient.
Interventions
Five case reports and one retrospective study reported the injection of
zona-free oocytes (Fig. 4). Ding et al. (1999) described the cases of
two couples inwhich one zona-free oocyte for each couplewas injected.
The polar bodies were not detectable. In both cases, the zona-free
oocytes fertilized, cleaved and developed to an early blastocyst success-
fully even though in the ﬁrst case, one blastomere degenerated in vitro at
4-cell stage. In one case, the early blastocystwas cryopreserved atDay6,
while in the second case, it was transferred together with a zona-intact,
expanded blastocyst to the recipient but implantation did not occur. In
both cases, the culture medium was renewed by removing the old
medium from the culture drop and replacing with fresh in order to
avoid the disintegration of the early embryos (Ding et al., 1999).
Takahashi et al. (1999) reported the case of a low-quality blastocyst
obtained from a zona-free injected MII oocyte which had been rescued
from a GV oocyte after an overnight in vitro culture. No information
was reported about the destiny of the blastocyst (Takahashi et al.,
1999). Stanger et al. (2001) reported the case of a couplewho presented
oocytes lacking a zona pellucida in two consecutive treatment cycles.
Since in the ﬁrst cycle, the injection of two zona-free oocytes resulted
in two arrested 4-cell stage embryos (probably due to the disassembling
of embryos during manipulation), they decided to inject the oocytes
without the removal of the coronal cells. Polar bodies were discernible
through the coronal cells. Two oocytes fertilized and were transferred
at Day 3 and a clinical pregnancy was established (Stanger et al., 2001).
Subsequently, Hsieh et al. (2001) reported the injection of a zona-free
MII oocyte that fertilized, developed to the 8-cell stage and was trans-
ferred with other zona-intact embryos. However, the implantation
failed (Hsieh et al., 2001).
More recently, Shu et al. (2010) reported two clinical pregnancies
following the transfer of vitriﬁed blastocysts developed from oocytes
without zona pellucida. In one of the two cases, the polar body was
not attached and on Day 2, all the four blastomeres of the early
embryo were inserted back into ruptured zona in order to prevent the
embryo from falling apart because there were loose contacts between
blastomeres. The same case resulted in an abortion at 22 weeks. In
the second case, the ﬁrst polar body was attached to the oocyte, tight
contacts between blastomeres were present on Day 2, and a healthy
baby was born (Shu et al., 2010).
Finally, Ueno et al. (2014) published a retrospective internally con-
trolled study in which the reproductive potential of 135 zona-free eggs
from minimally stimulated or natural cycles was compared with the
reproductive potential of 216 zona-intact oocytes. Meiotic spindles of
Figure 4 ICSI of zona-free oocyte (a–d). The polar body is not detectable. The oocyte fertilized (e) but resulted in one bad-quality embryo in Day 2 (f)
that arrested in Day 3. (a–e, 400× magniﬁcation; f, 200× magniﬁcation.)
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zona-free oocytes were conﬁrmed with polarized light microscopy. No
signiﬁcant differences in fertilization, cleavage, blastocyst formation, and
good-quality blastocyst rate were observed between zona-free and
zona-intact oocytes. Survival after thawing and live birth rate per
thawed blastocyst were also similar. Newborns originating from all
zona-free and zona-intact oocytes had a similar gestational age atdelivery
and birthweight (Ueno et al., 2014).
Based on this evidence, it can be concluded that zona-free mature
oocytes may be successfully fertilized with the use of ICSI, cultured
until the blastocyst stage and deriving blastocysts can be vitriﬁed for
further use. The basic neonatal outcome of resulting offspring is quite
reassuring. Appropriated care in the handling of zona-free oocytes and
subsequent early embryos should be used, namely the renewing of
medium leaving theembryoundisturbed.The transferof zona-freecleav-
age embryos should be avoided in order toprevent theblastomere falling
apart during manipulation and/or after transfer and blastocyst transfer
should be preferred (Ding et al., 1999; Stanger et al., 2001).
How to manage fertilization failure
Biological basis
Complete fertilization failure after ICSI is a rare event (1–3%) but does
happen even in the presence of apparently normal spermatozoa (Sousa
and Tesarik, 1994; Liu et al., 1995; Ludwig et al., 1999; Esfandiari et al.,
2005).Moreover, lowormoderate fertilization (,30%)canbeobserved
in repeated ICSI cycles for some patients (Montag et al., 2012).
The cause of fertilization failure after ICSI is different from that of con-
ventional IVF. In conventional IVF, 60–90% of the oocytes that failed to
fertilize do not contain sperm nuclei, suggesting penetration failure or
sperm ejection as the main cause of fertilization failure (Mahutte and
Arici, 2003). In contrast, 60–70% of unfertilized MII oocytes after ICSI
contain a swollen sperm head, indicating that oocyte was correctly
injected and that the principal cause of failed fertilization should have
been attributed to an oocyte-activation deﬁciency. Failure of oocyte
activation has been reported in 40–70% of unfertilized oocytes
exposed to ICSI (Sousa and Tesarik, 1994; Flaherty et al., 1995, 1998;
Rawe et al., 2000; Yamano et al., 2000; Yanagida, 2004). Other causes
include failed sperm head decondensation, premature sperm chromatin
condensation, spindle defects or sperm aster defects or simply incorrect
sperm injection (Swain and Pool, 2008). However, those causes are not
considered to contribute substantially to fertilization failure.
Oocyte activation consists of the releaseof themeiotic arrest convert-
ing theoocyte into a totipotent zygote able to formall types of body cells.
These events include cortical granule exocytosis, extrusionof the second
polar body, maternal RNA recruitment, formation of pronuclei and
initiation of embryonic gene expression (Horner and Wolfner, 2008).
There is a general consensus that the master key to initiate all the cyto-
logical changes in fertilized oocytes is represented by a series of intracel-
lularCa2+ rises that start shortly following spermatozoon–oocyte fusion
(Miyazaki and Ito, 2006; Ramadan et al., 2012). The binding of the male
gamete to the oolemma results in intracellular Ca2+ release within the
ooplasm, with an initial surge starting from the site of sperm penetration
and expanding as a wave through the oocyte. While one Ca2+ transient
wave is registered in echinoderm, ﬁsh, and frog oocytes, repetitive
calcium oscillations that last up to several hours are observed in
mammals. The nature, amplitude, duration and frequency of the Ca2+
signals are species-speciﬁc and are still a matter of debate. Moreover,
it is known that Ca2+ oscillations affect embryonic development
(Amdani et al., 2013).
The successof ICSI represents theproof that contactof spermandegg
plasma membranes is not a critical step for egg activation. However, egg
activation and subsequent development following ICSI are sperm-
speciﬁc and cannot be substituted by an artiﬁcial introduction of Ca2+
into the egg from the outside medium, and neither can insertion of a
glass pipette with or without the injection of culture medium sustain an
intracellular release of Ca2+ to activate the injected oocytes (Neri
et al., 2014). Substantial evidence suggests that oocyte activation is trig-
gered by a sperm factor, the phospholipase C z (PLCz). Once in the
oocyte’s cytosol, this physiological agent causes the production of
inositol-triphosphate (IP3) from the internal phospholipid phosphatidy-
linositol biphosphate stores,whichbinds to its receptor at theER.Ca2+ is
then released from these stores in an oscillatory mode. Indeed,
sperm-induced Ca2+ oscillations stimulate mitochondrial respiration
and, in turn, the resulting in ATP production required to maintain the
Ca2+waves. Recently, a close relationship between abnormal PLCz ex-
pression in the spermatozoa and failed oocyte activation and fertilization
was demonstrated in humans (Kashir et al., 2010; Amdani et al., 2013).
Of course, several oocyte elements that transduce the sperm-derived
signal to oocyte cell-cycle controlling systems via speciﬁc mechanism
are necessary. Indeed, cytoplasmic as well as nuclear maturation are
crucial steps for oocytes to obtain the ability to respond properly to
the sperm PLCz (reorganization of the ER, increase in the number of
IP3 receptors, increase in the concentration of Ca2+ ions stored in
ER etc.) (Kashir et al., 2010; Amdani et al., 2013).
Following ICSI fertilization failure, the issue is to establish whether the
fertilization failure should be attributed to a sperm- or an oocyte-related
fertilizationdeﬁciency.Casesofoocyte-activation failure canbe currently
treated by artiﬁcial oocyte activation (AOA) methods. Despite the fact
that treatment options in terms of AOA are the same for both male
and female deﬁciency, this represents crucial information both for the
physician and for the patients while discussing the prognosis and the
transmission risk when a genetic cause is involved. The diagnostic test,
usually offered to patients following total fertilization failure or very
low fertilization following ICSI, is the mouse oocyte-activation test
(MOAT; Rybouchkin et al., 1996; Heindryckx et al., 2005). MOAT com-
pares the activation percentage of mouse oocytes between ICSI using
spermatozoa from the patient and heterologous ICSI using control
spermatozoa (with proven activation capacity). According to the per-
centage of activated oocytes after MOAT, patients can be divided into
three groups: low-activation group (≤20%); intermediate-activation
group (21–84%); high-activation group (≥85%). A sperm-related
deﬁciency is very likely in the low-activation group, while it can be
refuted in most cases in the high-activation group. An inconclusive test
should be attributed to the intermediate-activation group results, since
both spermatozoa and oocyte deﬁciency may have contributed to
the previous ICSI fertilization failure (Heindryckx et al., 2005, 2008).
The best results in terms of AOA can be theoretically expected when
the MOAT test indicates a deﬁciency of the sperm oocyte-activating
ability, as in the case of globozoospermia. Indeed, poor or absent fertil-
ization during ICSI of the high-activation group could also be the result of
some transient biological reasons or technical imperfections. For this
reason, in the case of suspected oocyte-related fertilization failure, it is
advisable to seek conﬁrmation of actual fertilization failure by applying
AOA only on some oocytes (Heindryckx et al., 2008).
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Interventions
Asmentioned,oocyte-activation failurecanbecompensatedbyapproaches
that aim for an artiﬁcial cell Ca2+ entrance or release. A variety of artiﬁcial
activating methods is used in human ART, including physical, mechanical
or chemical stimuli (Table V).
Case reports related to this section are numerous.We herein discuss
the more relevant and a complete list is provided in Table V.
Mechanical method. A modiﬁed ICSI technique has been successfully
applied to obtain fertilization and pregnancy in patients with previous
total fertilization failure in two different studies, although limited to few
case reports (Table V). Tesarik et al. (2002) presented six cases, half
with sperm-born and half with oocyte-born oocyte-activation deﬁciency
inwhich normal fertilization and development of embryoswere restored
by amodiﬁed ICSI technique. In ﬁve of them, normal childrenwere born.
The modiﬁed ICSI consisted of a vigorous cytoplasmic aspiration from
the central areaof oocyte and its re-injection alongwith the spermatozoa
as close as possible to the oocyte periphery opposite to the puncture
site. The entire procedure has to be repeated two times. That vigorous
aspiration and repeated in-and-out movements of the microinjection
needle within the human oocyte could produce a considerable inﬂux
of Ca2+ from the surrounding culture medium and/or a mechanical dis-
ruption of ER and consequent releasing of the Ca2+ stored in this organ-
elle, probably causing the higher fertilization.Modiﬁed ICSI characterized
by aspiration close to the opposite site of injection, followed by central
deposition of the sperm, has been reported by Ebner et al. (2004).
The rationale was to accumulate the mitochondria with a high inner
membrane potential from the pericortical region to the center of the
oocyte, thus, theoretically, supplying more energy (ATP) directly to
the place where the spermatozoon was injected. The application of
this technique restored an adequate fertilization and pregnancy rate
(53 and 33.3%, respectively) in 14 patients with previous ICSI failure
with conventional ICSI. In the latter study, however, the causes of
previous fertilization failure were not provided (Ebner et al., 2004).
Physical method.Themost popular physical stimulus is electrical activation.
Animal studies have shown that anelectrical ﬁeld can generatemicropores
by moving charged proteins in the lipid bilayer of the cell membrane of
gametes and somatic cells. This would induce sufﬁcient Ca2+ inﬂux
through the pores to activate cytoplasm by means of Ca2+-dependent
mechanisms. Ithasbeendemonstrated that after thepeak inducedbyelec-
trical activation, the Ca2+ decreases to the original level in300 s. Yana-
gida et al. (1999) reported for the ﬁrst time the use of combined ICSI with
electrical stimulation in two coupleswith prior total failed fertilization after
ICSI, despite normal semen parameters. The oocytes were stimulated
with a single, square direct-current (DC) pulse (1.5 kV/cm, 100 ms)
30 min after ICSI. A 100% fertilization rate and a dizygotic twin birth in
one of the couples were reported. Another successful outcome was
reportedbyEgashira et al. (2009).Ahealthy femalewasbornbyusingelec-
trical oocyteactivation in acouplewhosemalepartnerwasaffectedby glo-
bozoospermia. In this study, in order to prevent the generation of reactive
oxygen species (ROS), asdemonstrated inpigs, the intensityand the length
of the DC pulse applied for activation were half of those previously
described (Egashira et al., 2009).
A different activation protocol was applied by Zhang et al. (1999) in a
prospective way on discarded oocytes that showed no evidence of
fertilization 16–24 h after ICSI. After an alternating current electrical
pulse of 8 V for 6 s, the oocytes were assigned to three treatment
groups: Group I (one DC pulse 1.36–1.50 kV/cm for 40–60 ms);
Group II (3 pulses every 15–20 min) and Group III (no DC pulse). Al-
though the fertilization rate was similar regardless of the number of the
electrical pulses applied, subsequent embryo development was dramat-
ically improved in those oocytes receiving three electrical pulses (Zhang
et al., 1999). Finally, twoprospective randomized studies have been pub-
lished more recently. Applying the same protocol of oocyte activation
published by Yanagida et al. (1999) to sibling oocytes from patients
with total fertilization failure in a previous ICSI, Baltaci et al. (2010)
found that electrically activated oocytes were capable of developing
into good-quality, healthy embryos, competent to establish ongoing
pregnancies. Degeneration rate due to electric stimulationwas reported
as 12% (Baltaci et al., 2010). Mansour et al. (2009) randomized sibling
oocytes from couples with severe oligoasthenoteratospermia and non-
obstructive azoospermia between electroactivation and no electroacti-
vation protocols. A double squareDCpulse to achieve the ﬁeld strength
of 2.6–2.8 kV/cm was used in this study and the fertilization rate was
reported as signiﬁcantly improved in the electroactivated group of
oocytes. Degeneration rate in electroactivated oocytes was 5.9% and
was not signiﬁcantly different between the twoprotocols. In all published
protocols, the electrical stimulation was applied 20–30 min after ICSI
(Mansour et al., 2009).
Chemical method. One of the chemical artiﬁcial activating agents which
has been described in human ART is strontium chloride (SrCl2). Unlike
electrical stimulation and Ca2+ ionophore treatment resulting in a
single transient increase in intracellular Ca2+, SrCl2 can induce Ca
2+
oscillations in mice more similar to the pattern seen with spontaneous
fertilization through a so far unclear mechanism. No oscillations are
observed in human oocytes after SrCl2 exposure. SrCl2 is thought to
move into the oocyte down the concentration gradient, causing Ca2+
to be released from the ER. It has been demonstrated that Ca2+ oscilla-
tions induced by SrCl2 are mediated by the IP3 receptor and require
PLCz activation and the synergistic action of IP3.
In the literature, few case reports using this compound can be found
(Table V). Yanagida et al. (2006) and Kyono et al. (2008) reported the
birth of seven healthy babies in patients with previous low or total fertil-
ization failure. In both papers, oocyte activation was performed incubat-
ing the oocyte, 30 min after ICSI, in a 10 mM SrCl2 solution for 60 min.
Kyono et al. (2008) also reported a normalmental and physical follow-up
of children from birth to 12 years old.
Ionophores, such as ionomycin or calmicyn (A23187), are the most
commonly used chemical artiﬁcial activating agents in ART practice. An
ionophore is a lipid-soluble molecule, usually synthetized by micro-
organism, which transports ions across the lipid bilayer of the cell mem-
brane, allowing extracellular Ca2+ to ﬂow into the cell. Ca2+ is released
also from its intracellular Ca2+ stores and in Xenopus ionomycin was
shown to act on the same intracellular Ca2+ stores as IP3. The artiﬁcially
induced Ca2+ rises do not mimic the physiologically sperm-induced
Ca2+ oscillations, as the exposure to any Ca2+ ionophore causes a
singular prolonged Ca2+ rise.
There is a certain variability in the protocols used in the various
studies and there are only few reports on AOA bymeans of ionophores
used for large number of ICSI patients (Table V).
We have described below the ﬁve main ionophore activation
protocols together with the different publications using them: (a) a
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TableV Summaryof the47papers identiﬁed inasystematic reviewof the literature inorder to investigatetheeffectivenessofassistedoocyteactivationduring ICSI
on embryo development and clinical outcomes.
Type of AOA Pro Study population MOAT ‘Rescue’
procedure
FR Cleavage
rate/good
EQ rate
BL rate CPR IR AbR LBR P/PR R/
CR/CS
study
Rybouchkin
et al. (1997)
Calcium
ionophore
(d) Globozoospermia + previuos
fertilization failure
Yes No — — — One ongoing
clinical
pregnancy
reported
— — — CR
Battaglia
et al. (1997)
Calcium
ionophore
(a) Globozoospermia + previuos
fertilization failure
No No — — — One
biochemical
pregnancy
reported
— — — CR
Yanagida et al.
(1999)
Electrical Previous fertilization failure Yes No — — — — — — Two live births reported CS
Zhang et al.
(1999)
Electrical Discarded unfertilized oocytes
after ICSI
No Yes Reactivated Reactivated Reactivated — — — — R
Tesarik et al.
(2000)
Calcium
ionophore
(a) Round spermatids and their
isolated nuclei
No No Normal
fertilization
reported
Normal
cleavage
reported only
for round
spermatids
— — — — — CS
Nakagawa
et al. (2001)
Calcium
ionophore
(e) Discarded unfertilized oocytes
after ICSI
No Yes Reactivated Reactivated — — — — — R
Kim et al. (2001) Calcium
ionophore
(a) Globozoospermia No No — — — — — — One live birth reported CR
Tesarik et al.
(2002)
Mechanical Globozoospermia + previous
fertilization failure
Yes No — — — — — — Six live births reported CR
Eldar-Geva et al.
(2003)
Calcium
ionophore
Previous fertilization failure No No — — — One ongoing
clinical
pregnancy
reported
One
miscarriage
reported
One live birth reported CR
Ebner et al.
(2004)
Mechanical Previous fertilization failure, no
indication
No No Improved
only in
fertilization
failure group
— Unchanged Improved
only in
fertilization
failure group
Improved
only in
fertilization
failure group
Unchanged — PR
Murase et al.
(2004)
Calcium
ionophore
(e) Previous fertilization failure No No — — — — — — One live birth reported CR
Chi et al. (2004) Calcium
ionophore
(a) Previous fertilization failure Yes No — — — — — — Twin live births reported CR
Heindryckx
et al. (2005)
Calcium
ionophore
(d) Previous fertilization failure Yes No Improved — — Improved — — — R
Moaz et al.
(2006)
Calcium
ionophore
(b) 100% abnormal sperm
morphology + previous
fertilization failure
No No Improved Unchanged — — — — — P
Lu et al. (2006) Calcium
ionophore
(e) Discarded unfertilized oocytes
after ICSI
No Yes Reactivated Reactivated — — — — — R
Continued
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Table V Continued
Type of AOA Pro Study population MOAT ‘Rescue’
procedure
FR Cleavage
rate/good
EQ rate
BL rate CPR IR AbR LBR P/PR R/
CR/CS
study
Yanagida et al.
(2006)
Strontium Previous fertilization failure No No Twin live births reported CR
Check et al.
(2007)
Calcium
ionophore
(a) Globozoospermia + previous
fertilization failure
No No Failed
fertilization
after AOA
— — — — — One live birth from sperm
donation
CR
Ahmady and
Michael (2007)
Calcium
ionophore
(a) Non-viable testicular sperm No No — — — — — — One live birth reported CR
Nasr-Esfahani
et al. (2008a, b)
Calcium
ionophore
(b) Abnormal sperm morphology No No Improved Improved — — — — — PR
Heindryckx
et al. (2008)
Calcium
ionophore
d) Previous fertilization failure Yes No Improved — — Improved — — — R
Tejera et al.
(2008)
Calcium
ionophore
(d) Globozoospermia + previous
fertilization failure
No No — — — — — — One live birth reported CR
Kyono et al.
(2008)
Strontium Previous fertilization failure No No Improved Improved — Improved Improved — Five live births reported CS
Dirican et al.
(2008a, b)
Mechanical Globozoospermia No No — — — — — — Two live births reported CS
Borges et al.
(2009a, b)
Calcium
ionophore
(a) General infertile population No No Unchanged Improved in
women ,36
and ejaculated
or epididymal
spz
— Unchanged Improved in
women ,36
and
ejaculated
spz
Unchanged — PR
Terada et al.
(2009)
Calcium
ionophore
(b) Previous fertilization failure Yes*
*bovine
oocytes
No — — — — — — One live birth reported CR
Borges et al.
(2009a, b)
Calcium
ionophore
(a) Surgically retrieved sperrm No No Unchanged Improved with
epididymal spz
— Unchanged Unchanged — — PR
Mansour et al.
(2009)
Electrical Oligoasthenospermia,
non-obstructive azoospermia
with total teratozospermia or
immotile sperm, previous
fertilization failure
No No Improved — — — — — Fifteen live births reported PR
Kyono et al.
(2009)
Calcium
ionophore
(a) Globozoospermia Yes No — — — — — — One live birth reported CR
Egashira et al.
(2009)
Electrical Globozoospermia + previous
fertilization failure
Yes No — — — — — — One live birth reported CR
Combelles et al.
(2010)
Calcium
ionophore
(c) Previous fertilization failure Yes No Failed
fertilization
after AOA
— — — — — — CR
Baltaci et al.
(2010)
Electrical Previous fertilization failure No No Improved Improved — Improved Improved — — PR
Isachenko et al.
(2010)
Calcium
ionophore
(a) Previous fertilization failure No No — — — One clinical
pregnancy
reported
— — — CR
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Taylor et al.
(2010)
Calcium
ionophore
(a) Globozoospermia No No — — — One ongoing
clinical
pregnancy
reported
— — — CR
Chen et al.
(2010)
Strontium Previous fertilization failure No No — — — — — — Four live births reported CS
Sugaya (2010) Calcium
ionophore
(a) Previous fertilization failure No No — — — — — — One live birth reported CR
Vanden
Meerschaut
et al. (2012)
Calcium
ionophore
(d) Previous fertilization
failure + oocyte-related
activation deﬁciency
Yes No Improved — — — — — — PR
Ebner et al.
(2012)
Calcium
ionophore
(a) Azoospermia,
criptozoospermia + previous
fertilization failure
No No Improved Unchanged Improved Improved Improved — Improved P
Montag et al.
(2012)
Calcium
ionophore
(a) Previous fertilization failure No No Improved — — Improved Improved in
previous
total
fertilization
failure group
Decreased in
previous total
fertilization
failure group
Improved in previous total
fertilization failure group
P
Kim et al. (2012) Strontium Previous fertilization failure No No — — — — — — One live birth reported CR
Lu et al. (2012) Calcium
ionophore
Previous fertilization failure No Yes — — — — — — One live birth reported CR
Kuentz et al.
(2013)
Calcium
ionophore
(d) Globozoospermia No No Improved — — Unchanged — Unchanged R
Yoon et al.
(2013)
Calcium
ionophore
(a) Previous fertilization failure No No Improved Improved — Improved Improved — Thirty-eight live births
reported
R
Vanden
Meerschaut
et al. (2014)
Calcium
ionophore
(d) — — — — — — — — — Normal neonatal and
neurodevelopmental
outcome of 21 children
≥3 years born following
AOA
R
Karaca et al.
(2014)
Calcium
ionophore
(a) Globozoospermia No No — — — — — — One live birth reported CR
Kim et al. (2014) Strontium Previous fertilization failure
with and without calcium
ionophore
No No — — — Five ongoing
clinical
pregnancies
reported
— — Eight live births reported.
Normal physical and
mental development up to
60 months
Ebner et al.
(2015)
Calcium
ionophore
(a) Previous fertilization failure
without severe male factor
No No Improved Unchanged Unchanged Unchanged Unchanged Unchanged Unchanged P
Kim et al. (2015) Calcium
ionophore
(a) Previous fertilization failure of
in vitro-matured oocytes
No No — — — — — — Twin live births reported CR
AOA, artiﬁcial oocyte activation; MOAT,mouse oocyte activation test; LBR, live birth rate; CS, case series; Pro ¼ protocol (only for calcium ionophore) (a) a single exposure of the oocytes, within 30–60 min from the injection, to 5–10 mMCa2+
ionophoreA23187 for 5–30 min; (b) a single exposure of the oocytes, within 30 min from the injection, to 10 mMCa2+ ionophore ionomycin for 10 min; (c) two consecutive exposures to 10 mM ionomycin for 10 min, 30 min apart (the time after
ICSIwasnot speciﬁed); (d) the injectionwith the spermatoonof 5 plCaCl2, 0.1 mM, followedafter 30 minof incubation in5–6%CO2atmosphere, by twoconsecutiveexposures to10 mMionomycin for 10 min, 30 min apart; (e) a single exposureof
the oocytes, after 30 min from the injection, to 5–10 mM Ca2+ ionophore A23187 for 5 min, followed by an incubation with 10 mg/ml puromycin for 4–5 h.
‘+’ symbol states the coexistence of both indications; previous fertilization failure include total failure, very low and low fertilization.
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single exposureof theoocytes,within 30–60min from the ICSI injection,
to 5–10 mM Ca2+ ionophore A23187 for 5 to 30 min.
(b) a single exposure of the oocytes within 30 min from the injection,
to 10 mM Ca2+ ionophore ionomycin for 10 min; (c) two consecutive
exposures to 10 mM ionomycin for 10 min, 30 min apart (the time
after ICSI was not speciﬁed); (d) the injection with the spermatozoan
of 5 pl of 0.1 mM CaCl2 followed after 30 min of incubation in 5–6%
CO2 atmosphere, by two consecutive exposures to ionomycin,
10 mM, for 10 min, 30 min apart; (e) a single exposure of the oocytes,
30 min from the injection, to 5–10 mM Ca2+ ionophore A23187 for
5 min, followed by an incubation with Puromycin, 10 mg/ml, for 4–5 h.
Protocol a. Borges et al. published two RCTs in 2009 (Table V; Borges
et al., 2009a, b). In the ﬁrst study, the effects of AOAwere evaluated on
314 ICSI cycles using spermatozoa from different sources (ejaculated,
epididymal and testicular). No signiﬁcant differences were observed
between conventional cycles and cycles with AOA.When the subgroup
of couples with women younger than 36 years and ejaculated spermato-
zoa was analyzed, the authors observed an increase in high-quality
embryos and implantation rate in cycles with AOA. In the same sub-
group,whenepididymal spermatozoawereused, thepercentageof high-
quality embryos was improved in cycles with AOA. In the second RCT,
the same authors consideredonly couples (n ¼ 204) undergoing surgical
sperm retrieval for ICSI. For patients undergoing testicular sperm aspir-
ation (TESA), AOA did not improve ICSI outcomes. A signiﬁcant
increased rate of high-quality embryos was observed with AOA only
with injected sperm retrieved from the epididymis, and no other advan-
tages were reported.
Montag et al. (2012) reported the results of using AOA in patient
cohorts with a history of no fertilization (0%—27 patients), fertilization
between 1 and 29% (38 patients) and fertilization between 30 and 50%
(24 patients) in initial ICSI cycles. The ﬁrst two groups of patients
brought the greatest advantage from the AOA, with a satisfactory fertil-
ization (41.6 and 44.4%, respectively), clinical pregnancy (18.8 and
31.4%, respectively) and take-homebaby rates (12.8and24.1%, respect-
ively). In the third group, however, a signiﬁcantly higher fertilization rate
was also reported (Montag et al., 2012).
Ebner et al. (2012, 2015) reported the results obtained with a
ready-to-use, commercially available Ca2+ ionophore A23187 in two
different multicentric prospective studies (Table V). In the ﬁrst study,
only couples with azoospermic or cryptozoospermic male partners
and previous low fertilization rates in previous cycles were included
(88 patients): higher fertilization, blastocyst formation, implantation
and take-home baby rates were reported for this group of patients
(Ebner et al., 2012). In the second multicenter study, patients with a
history of low fertilization (,50%) in previous ICSI cycles and without
severe male factor indications (101 patients) were considered: higher
fertilization rates compared with previous cycles were reported and
fewer patients had their embryo transfer cancelled compared with
their preceding treatment. All children (n ¼ 35) were born healthy
except for one male newborn who was diagnosed with anal atresia
(Ebner et al., 2015). These studies, however, might have the bias that
they have used previous cycles as control group.
Finally, it is worth mentioning the several case reports that have been
published (Table V). Four case reports have reported one biochemical
pregnancy, one ongoing pregnancy and two live births in couples with
a globozoospermic male partner (Battaglia et al., 1997; Kim et al.,
2001; Kyono et al., 2009; Taylor et al., 2010); two case reports have
described ﬁve live births in two couples with normozoospermic male
partners with repeated failed or very low fertilization rate (Eldar-Geva
et al., 2003; Chi et al., 2004); one clinical pregnancy in a couple with an
asthenozoospermic patient with low fertilization rate has been reported
(Isachenko et al., 2010); one full term delivery from a patient with only
non-viable testicular spermatozoa (Ahmady and Michael, 2007) and a
twin pregnancy in a cycle of in vitro-matured oocyte (Kim et al., 2015)
have been also described. Notably, a report of a fertilization failure has
also been reported in a globozoospermic patient, although sibling
oocytes injected with donor sperm did fertilize (Check et al., 2007).
Finally, we believe that we should mention the article of Tesarik et al.
(2000), who reported a normal fertilization rate of oocytes injected
with round spermatids after oocyte activation with Ca2+ ionophore.
The authors did not report if the embryos obtained implanted and we
did not ﬁnd any similar study in the literature, but their data should
encourage further research on this topic.
Protocol b.Ahigher fertilization ratewas reported in aprospective studyon
sibling oocytes in selected cases (n ¼ 56) with a previous history of failed
or low (,40%) fertilization rate and100%spermabnormality (Moaz et al.,
2006). Similar results were reported also from another group in a pro-
spective study on sibling oocytes in which 87 couples with severe terato-
zoospermia were involved. In this study, however, a signiﬁcant increment
of fertilization ratewas reported only for the study groups of oocytes that
had poor (,33%) or moderate (34–65%) fertilization rate in their re-
spective control groups. Greater beneﬁts were also found on fertilization
rates for the semen samples with immotile sperm compared with those
with motile sperm (Nasr-Esfahani et al., 2008a). It is worth mentioning
for this protocol a case report of a clinical pregnancy obtained in a
couple with total fertilization failure in previous cycles due to sperm
centrosomal dysfunction (Terada et al., 2009; Table V).
Protocol c. Only a case report is available in the literature, in which a
fertilization failure even after AOA is described. The oocytes were
ﬁxed for cytological examination and multiple polar bodies and two dis-
organized spindle structures were predominantly observed, pointing
toward a cytoplasmic defect in the oocytes as the primary cause of the
couple’s infertility (Combelles et al., 2010).
Protocol d. Heindryckx et al. (2005, 2008) published two studies both
reporting the restoring of normal fertilization and pregnancy rates after
AOA in a group of patients with failed or low fertilization rate
(Table V). MOAT was used to distinguish between sperm-related and
oocyte-related activation deﬁciency. In the ﬁrst study on 17 patients
(including 6 patients with globozoospermia), a fertilization rate of 77
and 71% was reported in the sperm- and oocyte-related deﬁciency
groups, respectively, with 5 pregnancies in the globozoospermia group
and 3 in cases of oocyte-related fertilization failure (Heindryckx et al.,
2005). In the second study (30 patients), fertilization and pregnancy
rateswere signiﬁcantly increased for all the three groups of patients iden-
tiﬁedwithMOAT (respectively, 75 and 34% for low-activation group; 73
and 43% for intermediate-activation group and 75 and 17% for high-
activation group). All pregnancies gave rise to healthy infants with no
major or minor malformations (Heindryckx et al., 2008). These studies
highlighted how even when MOAT reveals no activation deﬁciency
in spermatozoa, assisted AOA still allows for high fertilization rate.
Further evidence on the efﬁcacy of AOA also for patients with an
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oocyte-related activation deﬁciency was published by Vanden
Meerschaut et al. (2012). In a prospective study on sibling oocytes,
ICSI followed by AOA was able to improve fertilization rate (74.2
versus43.5%) in coupleswithprevious total fertilization failureor low fer-
tilization and with a suspected oocyte-related fertilization problem.
However, at least, in cases from other ART centers, a split of oocytes
between conventional ICSI and ICSI followed by AOA should be pro-
posed as a ﬁrst option, in order to distinguish between a molecular
oocyte-related activation deﬁciency and previous technical or other bio-
logical failures (Vanden Meerschaut et al., 2012).
Finally, Tejera et al. (2008) reported a healthy newbornwith the appli-
cation of this AOA protocol after ICSI in a couple with a globozoosper-
mic male partner (Tejera et al., 2008).
Recently, VandenMeerschaut et al. (2014) reported the neonatal, be-
havioral and neurodevelopmental outcomes of 21 children aged ≥3
years who had been born following AOA. The data obtained were re-
assuring because, for all the tests, the mean outcomes lay within the
expected ranges (Vanden Meerschaut et al., 2014).
For the description of the study byKuentz et al. (2013), we refer to the
section ‘How to manage globozoospermia’.
Protocol e. Two studies reported the rescue of the oocytes that were un-
fertilized after ICSI (Table V). Both studies reported a high activation rate
(.80%), although it was differently deﬁned in the two studies. Lu et al.
(2006) considered activated oocytes as oocytes that showed at least
one pronucleus or oocytes that immediately cleaved, while Nakagawa
et al. (2001) considered the activation rate as the proportion of the
oocytes that showed two pronuclei with the second polar body.
Chromosomal analysis applied to a subset of embryos derived from
activated oocytes showed in both studies a normal diploid set of
chromosomes. In particular, Lu et al. (2006) reported the presence of
the Y chromosome in cleaving embryos. This would suggest that one
pronucleus in the fertilized oocytes after activation originated from an
injected spermatozoon and that embryos were not parthenogenones.
The authors observed that the best results in terms of oocyte activation
anddevelopment potential of activatedoocyteswereobtainedwhen the
oocyte activationwas performed 20 h after ICSI and not later, suggesting
that the function of organelles in oocytes is still maintained after this
period. These results were encouraging for the possibility to rescue
the oocytes in cases of total fertilization failure, especially if the
oocytes are activated as soon as the total fertilization failure is recorded.
However, the fate of embryos obtained from rescued oocytes was not
described.
Finally, Murase et al. (2004) reported the delivery of a healthy male
infant in an ICSI cycle with AOA in a couple with a normozoospermic
male partner and previous repeated failed fertilizations.
Although the single study on the neurodevelopmental outcomes in
children aged between 3 and 10 years is reassuring, prospective multi-
center long-term studies are needed to draw deﬁnite conclusions
about the safety of this technique. We can comment that this is not
the only technique routinely applied in human IVF missing prospective
multicentric long-term studies (Gleicher et al., 2013).However, themar-
keting of a ready-to-use ionophore solution has been viewed as an impri-
matur of safety not well accepted by some authors (van Blerkom et al.,
2015). It is true however that nowadays, a standardization of procedure
is still missing, toomany different protocols have been published and the
literature reports mainly cases based on few patients. While molecular
research is conducted on the effects of the altered pattern of Ca2+ oscil-
lation caused by AOA, clinicians should aim for standardization of the
AOAprocedure, and a strict follow-up of children should be established.
Hence, ICSI combined with AOA should be still performed only in cases
where a clear indication is present and should be considered an experi-
mental procedure.
At present, there is a great interest in PLCz as the activating agent
because of its physiologic activity and we expect signiﬁcant progresses
in the near future (Amdani et al., 2013).
ICSI andmale gametes
As ICSI is the gold standard technique for male factor infertility, a great
effort has beendirectedover the years toward the improvement of the se-
lection of euploid viable spermatozoa, with intact DNA (Oehninger,
2011). This has resulted in a huge amount of papers addressing these
topics, which will not be discussed extensively here. The aim of this
section is to review and discuss only the studies that have evaluated the ef-
fectiveness of advanced sperm selection methods in terms of ICSI results.
How to manage globozoospermia
Biological basis
Globozoospermiawas ﬁrst described in 1971 as a very rare typeofmono-
morphic teratozoospermiaobserved in,0.1%of infertilemales. It is char-
acterized by round-headed spermatozoa with an absent acrosome, an
aberrant nuclear membrane and midpiece defects (Singh, 1992; Dam
et al., 2007a, b).
During spermiogenesis, the acrosome is formed by the Golgi appar-
atusof thedeveloping spermatocyte.Afterpositioningof theprospective
acrosomal cap, the sperm head is remodeled by the cytoskeleton to a
species-speciﬁc shape. In patients with globozoospermia, this process
does not occur, leaving spermatozoa with a characteristic round-head
appearance (Kang-Decker et al., 2001; Yao et al., 2002; Xiao et al.,
2009). The acrosomeless spermatozoon is unable to go through the
zona pellucida and fuse with the oolemma of the oocyte (Aitken et al.,
1990; Dale et al., 1994; Rybouchkin et al., 1996).
There is a groupof patientswhose semen samples showonly a fraction
of spermatozoa with this typical head shape. This condition was
described 2 years after the ﬁrst description of globozoospermia and
the term ‘partial’ globozoospermia is often used in patients with
,100% of the sperm cells showing a round-headed form without an
acrosome (Holstein et al., 1973). These cases are more common in
daily clinical practice than total globozoospermia. Although there is no
deﬁned threshold for thenormal proportionof round-headed spermato-
zoa in anejaculate, it iswell known thateven fertilemencanhaveup to3%
round-headed sperm cells in the ejaculate (Kalahanis et al., 2002). The
presence of consanguineous marriage in families affected with globo-
zoospermia and reports of two ormore sibs in several families suggested
a genetic contribution to globozoospermia in humanswith autosomal re-
cessive mode of inheritance. Three genes with potential involvement in
globozoospermia [SPATA16 (spermatogenesis associated 16), PICK1
(protein interacting with PRKCA 1) and DPY19L2 (one of a transmem-
brane gene family)] segregating on an autosomal recessive mode have
now been identiﬁed (Florke-Gerloff et al., 1984; Carrell et al., 1999;
Kilani et al., 2004; Dam et al., 2007b; Dirican et al., 2008a; Liu et al.,
2010; Harbuz et al., 2011; Koscinski et al., 2011; Perrin et al., 2013).
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These ﬁndings reinforce the idea of amultigenic disorder inwhich several
etiologies may cause the same morphologic phenotype.
Globozoospermic men had a sperm fragmentation index statistically
signiﬁcantly higher than fertilemen but just a slight increase in aneuploidy
rate compared with fertile men (Perrin et al., 2013). Until the advent of
ICSI in 1992, globozoospermia was considered intractable.
However, unfortunately, the fertilization and birth rates obtained fol-
lowing conventional ICSI areextremely low in globozoospermic patients.
Recent reports suggest that globozoospermia is associatedwith a signiﬁ-
cant reduction in, or even the absence of, the sperm factor PLCz and of
perinuclear theca proteins (Heytens et al., 2009; Oko and Sutovsky,
2009; Alvarez Sedo et al., 2012). This might explain the very low or
absent fertilization in globozoospermic patients because, as reported
above, PLCz is thought to be the main physiologic factor responsible
for oocyte activation (Oko and Sutovsky, 2009).
Interventions
Although spontaneous activation of the oocyte after ICSI has been
reported in some cases of globozoospermia (Lundin et al., 1994; Kilani
et al., 1998; Stone et al., 2000; Nardo et al., 2002; Zeyneloglu et al.,
2002; Bankeret al., 2009; Bechoua et al., 2009; Sahu et al., 2010; Sermon-
dade et al., 2011; Zhang et al., 2015), Zhang et al. (2015) have suggested
that ICSI without AOAmay be useful especially in cases of partial globo-
zoospermia, because partial globozoospermia implies the presence of
normal sperm cells that may be used in a clinical setting. On the other
hand, Rybouchkin et al. (1997) have demonstrated that the rates of fer-
tilization and embryo development in ICSI using round-headed sperm
improved when a calcium ionophore was used for oocyte activation
after microinjection. Activations of the oocytes by chemical agents
(Rybouchkin et al., 1997; Battaglia et al., 1997; Kim et al., 2001; Check
et al., 2007; Tejera et al., 2008; Kyono et al., 2009; Taylor et al., 2010;
Kuentz et al., 2013), mechanical methods (Tesarik et al., 2002; Dirican
et al., 2008a) and electrical stimuli (Egashira et al., 2009) have been sug-
gested and we refer to the section ‘How to manage fertilization failure’
for further details.
Interestingly, Kuentz et al. (2013)observed, in a retrospective studyon
34 globozoospermic patients, that the fertilization rate with AOA, by
means of calcium ionophore, was restored to normal when compared
with conventional ICSI, regardless of the presence of a DPY19L2 muta-
tion. In any case, when using conventional ICSI, globozoospermic
DPY19L2-mutated patients had a better, although very low, fertilization
rate than globozoospermic DPY19L2 non-mutated patients (Kuentz
et al., 2013). Probably, in the case of globozoospermia and especially
in partial globozoospermia, it is advisable to apply AOA only to some
of the oocytes in order to check the oocyte-activation ability of
spermatozoa.
How to manage absolute asthenozoospermia
Biological basis
Absolute asthenozoospermia (the condition in which only immotile
spermatozoa can be retrieved) is reported at a frequency of 1 in 5000
men and it implies a very poor fertility prognosis. Diagnosis, etiology
and treatment of absolute asthenozoospermia have been already very
well reviewed by Ortega et al. (2011) who reported that the injection
of a completely immotile spermatozoon has an overall negative impact
on fertilization and pregnancy rates. The obvious reason lies in the fact
that immotile viable spermatozoa cannot be distinguished from immotile
non-viable spermatozoa. Indeed, beyond the defects of the motor
apparatus that can be found in genetic defects, such as Kartagener’s syn-
drome or dysplasia of ﬁbrous sheath or defective centrosome, a major
condition associated with immotile sperm is necrozoospermia (Nagy,
2000), which is a passive, catabolic and degenerative process that ends
in cell death.Onlyonebirth resulting from injectionof killed spermatozoa
by freezing without cryoprotectant was reported (Hoshi et al., 1994).
However, viability staining following the ‘killing’ process was not per-
formed, raising the possibility that the sperm used might have been
immobilized but were not dead. Early experiments with proved non-
viable spermatozoa demonstrated that they were able to fertilize but
with very poor results (16.2–17.5%) and embryo development was
heavily compromised (Poe-Zeigler et al., 1997; Ahmadi and Ng, 1999).
Interestingly, basedon experiments in animals, fertilization and blasto-
cyst formation rate increased to normal level when a cytosolic sperm
factor, obtained by lysing and centrifuging a sperm suspension, was
co-injected with non-viable spermatozoa, suggesting that poor fertiliza-
tion could bedue to the inability of non-viable spermatozoa to trigger the
activation process of the oocytes (Ahmadi and Ng, 1999). Indeed, in all
mammalian species studied to date, normal oocyte fertilization and
development follow a speciﬁc intracellular Ca2+ oscillation (see the Fer-
tilization Failure, Biological basis section). Experiments with human
spermatozoa killed by sonication and injected into mouse oocytes
show that embryo development to blastocyst stage and the rate of
normal Ca2+ oscillation declined after a short maintenance interval
between sonication and injection, with the Ca2+ response as the most
sensitive parameter affected, directly demonstrating the inability of non-
viable spermatozoa to activate the oocytes (Yazawa et al., 2009).
Interventions
In daily laboratory routine, selectionmethods currently used to choose a
viable sperm for ICSI in the case of absolute asthenozoospermia are
based on chemical substances added to the sample before the proced-
ure, or biophysical approaches accomplished during the procedure. In
the case of 100% necrozoospermia in the ejaculate, ICSI should be
performed in combination with TESE using methods for selecting
viable testicular spermatozoa (Ortega et al., 2011).
Improvement of the sperm sample before ICSI procedure: pentoxifylline treat-
ment. Pentoxifylline is a methylxanthine derivative that causes a non-
selective inhibition of phosphodiesterase (PDE) leading to augmented
generation of cyclic nucleotides such as cAMP and cyclic guanosine
monophosphate. The compound is much in demand as a cardiovascular
drug and has beenwidely used to ameliorate peripheral vascular diseases
since it enhances blood cell ﬂowand acts as a vasodilator.On sperm, the
drug acts via the cyclic AMP pathway to induce downstream sperm tail
protein phosphorylation, thus stimulating motility (Yovich, 1993). The
effectiveness on ICSI outcome of pentoxyfylline, as a selective inhibitor
of PDEable to stimulate spermmotility in cases of absolute asthenozoos-
permia, has been investigated by a total of four clinical studies and three
case reports (Table VI).
A retrospective analysis of 47 ICSI cycles using immotile testicular
sperm treated with pentoxifylline has demonstrated a signiﬁcantly
higher fertilization rate compared with 30 ICSI cycles using unselected
immotile sperm, but the other outcomes were similar (Kovacic et al.,
2006). In this study, the ﬁnal concentration of pentoxyfylline used was
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Table VI Summary of 25 papers identiﬁed in a systematic review of the literature in order to investigate the effects of selection methods to manage absolute
asthenozoospermia before ICSI on embryo development and clinical outcomes.
Sperm sample Notes FR Good EQ
rate
Cleavage
rate
BL rate CPR IR AbR LBR P/PR/R/
CR/CS
study
Before ICSI
procedure
Chemical
substances
Nodar et al.
(1999)
Ejaculated Klinefelter’s syndrome — — — — — — — Twin live births CR
Terriou et al.
(2000)
Fresh–frozen
epididimal and TESE
Immotile PF treated versus
motile untreated
Unchanged — Unchanged — Unchanged — — — P
Griveau et al.
(2006)
Frozen–thawed TESE Immotile PF treated versus
motile untreated
Reduced — — — Unchanged Unchanged Unchanged Unchanged P
Kovacic et al.
(2006)
TESA/TESE Immotile PF treated versus
untreated
Improved — — Unchanged Unchanged — Unchanged — R
Yildirim et al.
(2009)
Ejaculated Primary ciliary dyskinesia — — — — — — — Triplet live births CR
Ebner et al.
(2011)
Frozen–thawed TESE Theophylline treated
versus untreated
Improved Unchanged Improved Improved Improved Improved — Improved PR
Hattori et al.
(2011)
Ejaculated Kartagener’s syndrome — — — — — — — One live birth CR
Mangoli et al.
(2011)
TESE PF versus HOS Improved — Unchanged — Improved — — PR
Ebner et al.
(2014)
Ejaculated Immotile theophylline
treated
— — — — — — — One live birth CR
During ICSI
procedure
STFT de Oliveira
et al. (2004)
TESE Motile versus immotile
(fresh and frozen–thawed)
Unchanged — Unchanged — Unchanged Unchanged Unchanged Unchanged R
HOS Casper et al.
(1996)
Ejaculated-thawed
epididymal
HOS versus random
selection
Improved — Improved — Improved — — Three
pregnancies in
eight cycles
P
Liu et al. (1997) Ejaculated and TESE HOS selection — — — — One ongoing
clinical
pregnancy
— — — CS
Barros et al.
(1997a, b)
Ejaculated Total immotile after
penthoxyphilline
— — — — Two ongoing
clinical
pregnancies
— — Two healthy
children
CS
During ICSI
procedure HOS Ved et al.
(1997)
Ejaculated — — — — — One clinical
pregnancy
— — — CR
El-Nour et al.
(2001)
Ejaculated HOS versus random
selection
Unchanged Unchanged — — Unchanged Unchanged — — P
Sallam et al.
(2001)
Ejaculated and TESE HOS ejaculated versus
HOS TESE
Unchanged Unchanged Unchanged Unchanged Unchanged — R
Westlander
et al. (2003)
Ejaculated and TESE Kartagener’s syndrome;
HOS ejaculated versus
HOS TESE
— — — — Two clinical
pregnancies
— — — CS
Peeraer et al.
(2004)
Ejaculated Immotile cilia syndrome — — — — One clinical
pregnancy
— One
miscarriage
— CR
Sallam et al.
(2005)
TESE HOS versus morphology Improved Improved — — Improved Unchanged — — PR
Continued
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1.76 mM and the identiﬁcation and isolation of motile spermatozoa
started after a 20 min incubation. Two prospective studies showed
that ICSI cycles performedusing fresh or frozen epididymal and testicular
pentoxifylline-treated immotile spermatozoa have similar outcomes in
terms of clinical pregnancy rates compared with ICSI cycles using spon-
taneously motile spermatozoa, indirectly supporting the efﬁcacy of the
compound treatment (Terriou et al., 2000;Griveau et al., 2006). Pentox-
yfylline was used at a ﬁnal concentration of 3.6 and 1.5 mMwith an incu-
bation time of 10 min. As previously reported, a single randomized
prospective study has demonstrated that pentoxifylline treatment
(0.6 mM for 15 min) would be superior to hypo-osmotic swelling test
(HOS) selection in TESE-recovered sperm for ICSI in terms of fertiliza-
tion and pregnancy rates (Mangoli et al., 2011). The sperm treatment
with pentoxifylline is thought to be currently used, or to have been
used in the past, in hundreds of laboratory worldwide: therefore, the
limited evidence available for evaluating its usefulness is as unexpected
as the lack of standardization of the protocols. Serious concerns have
been raised regarding the potential embryotoxicity of pentoxifylline
becauseof the controversial resultsderived fromthe analysis of this com-
pound on animal embryo development (Tournaye et al., 1993; Ain and
Seshagiri, 1997). Thus, surprising is also the paucity of data regarding
the babies born from this procedure, leaving a tremendous gap of knowl-
edge in relation to its safety. Further studies are needed in this context.
Finally, three case reportsdescribed theoccurrenceofapregnancyafter
ICSI performed by using pentoxyfylline-selected sperms in complete aste-
nozoospermic patients diagnosed with genetic syndromes such as Karta-
gener’s syndrome (Hattori et al., 2011), Klinefelter’s syndrome (Nodar
et al., 1999) and primary ciliary dyskinesia (Yildirim et al., 2009).
Improvement of the sperm sample before ICSI procedure: theophilline treat-
ment. Theophylline is a weak non-selective inhibitor of PDE isoenzymes
leading to increased intracellular concentrations of cAMP and cyclic 3′,5′
guanosine monophosphate. Theophylline would appear to be superior
to pentoxifylline because of its increased half-life. A single group has
investigated the usefulness of theophylline treatment instead of pentox-
ifylline (Ebner et al., 2011) in a prospective study on thawed testicular
sperm selected for ICSI in which a ready-to-use commercially available
compound was used. Theophylline-treated thawed sperm compared
with untreated sperm showed a signiﬁcant improvement in searching
time, increased fertilization andblastulation rates andhigher implantation
and clinical pregnancy rates. In a recent case report (Ebner et al., 2014),
theophylline has been demonstrated to be an efﬁcient agent for stimulat-
ing immotile spermatozoa also in a patient with retrograde ejaculation
and total sperm asthenozoospermia, and a healthy live birth was
reported. It should however be considered that also for theophylline, a
teratogenic effect has been reported in rodents and reproductive
studies are recommended in the evaluation of the compound (National
Toxicology Program, 1998).
Selection of sperm during ICSI procedure: the sperm tail ﬂexibility test. The
sperm tail ﬂexibility test (STFT) represents a procedure developed to
select viable immotile spermatozoabasedon theobservation that immo-
tile viable sperms have a ﬂexible tail (Soares et al., 2003). If the tail bends
and recovers its original position, the sperm is considered viable, while
sperm rigidity and incapacity to recover to the initial tail position is con-
sidered a sign of non-viability. Others consider the sperm viable if the tail
moves up and down independently of the head movement and non-
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viable when head and tail move together when touched. There are con-
cerns over the clinical routine use of this test. First of all, STFT needs la-
boratory staff with a high level of experience and skills. Furthermore,
concerns have been raised about the use of this procedure for cryopre-
served and thawed sperms, because of their, if any, spontaneous tail
curling (Nordhoff, 2015). Only one retrospective study has investigated
the clinical usefulness of STFT in ICSI practice (Table VI). deOliveira et al.
(2004) reported no signiﬁcant differences in fertilization, pregnancy rates
and take-home baby percentages achieved using motile versus immotile
STFT-selected sperms. It shouldbeconsidered thatnoprospective study
has been published comparing STFTwith others procedures used in ICSI
practice, thus the beneﬁts of the method in terms of reproductive
outcome improvements remain to be proved.
Selection of spermduring ICSI procedure:HOS.TheHOSisa simple, safe and
repeatable alternative method allowing the identiﬁcation of live and intact
spermatozoa; exposure to hypo-osmotic conditions (75 mM fructose,
25 mMsodiumcitratedehydrate) induces in cells different tail swelling pat-
terns, due to water inﬂux, which are classiﬁed from a-sperm to g-sperm
(Casperet al., 1996;WHO,2010). Patterna spermatozoahavenoexpan-
sion and are considered non-viable and non-functional and their use
should be avoided during ICSI (Stanger et al., 2010; Bassiri et al., 2012);
pattern b to g sperm have different tail morphologies as described by
the World Health Organization (WHO, 2010) and are considered
viable spermatozoa. The main disadvantages of this procedure are
related to the possible steric problems arising from hypo-osmotic expos-
ure and to false-positive as well as false-negative results (Barros et al.,
1997a, b; Bollendorf et al., 2012).Although this technique is certainly time-
consuming, it has been proven to work also for spermatozoa extracted
from testicular biopsies (Sallam et al., 2001, 2005; Bollendorf et al.,
2012).However,HOS is not suitable for spermatozoa that havebeenpro-
cessed, speciﬁcally cryopreserved then thawed, as these cells spontan-
eously develop tail swelling (Hossain et al., 2010).
Apart from sporadic reports of successful results (Barros et al., 1997a,
b; Ved et al., 1997; Liu et al., 1997), the effectiveness of this procedure in
terms of ICSI outcome improvement has been evaluated by ﬁve clinical
studies (Table VI). Casper et al. (1996) reported in a limited number of
cycles an increased fertilization and cleavage rate after injection of HOS-
selected sperm(to43and39%, respectively) in comparisonwith random
sperm injectionwhere the fertilization and cleavage rateswere lower (26
and 23%, respectively). A total of three pregnancies in the eight cycles
with HOS-selected spermatozoa, including two from frozen epididymal
sperms, were obtained. The effectiveness of HOS-selected ‘live’ sperm
versus non-selected sperm on ICSI outcomes was, however, not
conﬁrmed in a prospective study involving 30 ICSI cycles by El-Nour
et al. (2001). Sallam et al. (2001) retrospectively analyzed ICSI outcomes
of ejaculated versus testicular sperms when sperm selection was per-
formed according to a modiﬁed HOS procedure (50% culture
medium + 50% Milli-Q grade water). There were no statistically signiﬁ-
cant differences between the ejaculated and the testicular spermgroup in
fertilization, cleavage, pregnancy and implantation rates or in the deliv-
ery/ongoing pregnancy rates. Two RCTs have been performed. The
samegroup in2005 (Sallam et al., 2005) carriedout anRCTbycomparing
the use of the HOS procedure with the morphology selection alone for
testicular sperm samples: higher fertilization, embryo quality, pregnancy
and ongoing pregnancy rates were demonstrated in the HOS group.
Nevertheless, Mangoli et al. (2011) analyzed use of the HOS method
in comparison to pentoxifyilline treatment in TESE-recovered sperms
for ICSI: lower fertilization and pregnancy rateswere observed forHOS-
selected samples.
The HOS selection strategy has been successfully applied in cases of
both Kartagener’s syndrome and immotile cilia syndrome (Peeraer
et al., 2004; Kordus et al., 2008; Geber et al., 2012). Interestingly,West-
lander et al. (2003) compared HOS selection of ejaculated or testicular
recovered sperms in two patients affected by Kartagener’s syndrome,
obtaining fertilization, good-quality embryos and twoclinical pregnancies
by using TESE together with HOS selection.
Selection of sperm during ICSI procedure: laser shot system. An alternative
method for the identiﬁcation of immotile sperm that are viable is based
on a single laser shot through a non-contact 1.48 mm diode laser
system, directed to the tip of the ﬂagellum, which in a live immotile
sperm causes a coiling of the tail at the site of impact (Aktan et al.,
2004). The method appears to be quick, easy, repeatable and, even if a
speciﬁc expertise is needed, its speciﬁcity in identifying viable sperms
seems comparable to that of the HOS system (Nordhoff et al., 2013).
The use of the laser-selected spermatozoa for ICSI in ejaculated absolute
asthenozoospermic samples has been investigated in two clinical studies
and in a case report (Table VI). In a prospective randomized study,
Aktan et al. (2004) have achieved signiﬁcantly higher fertilization and cleav-
age rates selecting immotile sperm frombothTESE andejaculated samples
using the laser versus random selection. A trend toward a higher take-
home baby rate was also reported, but the number of patients was too
low todeﬁne the statistical signiﬁcance.A signiﬁcant increase in fertilization
rate in TESE–ICSI cycles was also obtainedwhen laser-assisted sperm se-
lection was applied in comparison to the morphologic method (Nordhoff
etal., 2013).Acasereporthasdescribed theachievementofpregnancy ina
couple with an infertile man with primary ciliary dyskinesia by using laser-
assisted sperm selection before ICSI (Gerber et al., 2008).
How to manage DNA fragmentation
Biological basis
An increasingly popular topic is the study of spermDNA fragmentation.
The main pathway leading to sperm DNA breaks is a process of apop-
tosis triggered by testicular conditions and by oxidative stress during
the transit in the male genital tract (Muratori et al., 2015). Once the
sperm nucleus has been delivered into the ooplasm, the condensed
nucleus must decondense rapidly to release the DNA for formation of
a paternal pronucleus. Any abnormal change in the structural organiza-
tion can cause delays or defects in the delivery of the paternal DNA.
Moreover, anydamage to theDNAduring the transition fromthe testicle
to the oocyte cannot be repaired until the DNA is accessible for DNA
repair systems in the ooplasm. The risk of error during the repair
process increaseswith the numberofDNAstrand breaks in an individual
sperm nucleus. Experiments in animals have demonstrated that when
sperm induced to undergo to chromatin fragmentation by divalent
cations were used to fertilized oocytes, the replication of the paternal
pronucleus was severely delayed and if the damage is severe enough
embryo development can be arrested (Gawecka et al., 2013). This phe-
nomenon suggests that there might be a mechanism that stops replica-
tion forks in the presence of double-stranded breaks probably allowing
the DNA to be repaired (Gawecka et al., 2015). Conversely, when the
DNA damage is less severe (prevalence of single-stranded breaks),
there is no detectable delay in the DNA synthesis but chromosomal
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breaks are detected at mitosis demonstrating that DNA synthesis is
possible in the zygote with some breaks (Gawecka et al., 2013). In
both cases, embryo development might be compromised. These are
the reasons why the injection of a spermatozoa with fragmented DNA
can be detrimental.
The causes of DNA fragmentation have already been extensively
reviewed (Lewis and Aitken, 2005; Gonza´lez-Marı´n et al., 2012;
Wright et al., 2014) and a huge amount of studies have investigated the
relationship between ART outcomes and high DNA damage in sperm.
Thus, outstanding reviews have described in details these studies,
drawing the conclusion that contradictory evidence is associated with
the importance of male gamete DNA fragmentation in predicting fertil-
ization, embryo development, implantation, birth defects in the offspring
and early pregnancy loss (Gandini et al., 2004; Huang et al., 2005; Borini
et al., 2006; Bungum et al., 2007; Simon et al., 2011; Sakkas, 2013;
Palermo et al., 2014) and we do not further discuss this topic.
Notwithstanding this, the strategy to identify those spermatozoa that
are abnormal has gained popularity. DNAdamage assays are just starting
to be evaluated in a critical manner and the in-depth discussion about
their clinical relevance in predicting clinical outcomes can be found else-
where (Harper et al., 2012; Palermo et al., 2014).
Interventions
To date, there is no reliable approach to completely ﬁlter out spermato-
zoawith DNA strand breaks from an ejaculate (Zini et al., 2000; Gandini
et al., 2004; Stevanato et al., 2008; Ebner et al., 2011). In daily laboratory
routine, two major categories of selection method are currently used:
those aiming to enhance the number of spermatozoa with intact DNA
in the sperm population used for ICSI and those aiming to isolate the
single spermatozoon with the lowest chance of having fragmented
DNA for the injection.
Improvement of the sperm sample before ICSI procedure: annexin V–magnet-
ic activated cell sorting.Asmentioned, themain pathway leading to sperm
DNA breaks is a process of apoptosis (Gorczyca et al., 1993; Muratori
et al., 2015).During theearly eventsof apoptosis, thephospholipid phos-
phatidylserine (PS), which is usually located in the cytosolic leaf of the
plasma membrane lipid bilayer, shows a redistribution from the inner
to the outer leaf (Shen et al., 2002). In necrosis, PS becomes accessible
due to the disruption of membrane integrity. Annexin V is a major cell
membrane component of macrophages that binds selectively PS in a
Ca2+-dependent manner. The approach combining density gradient
centrifugation with annexin V–magnetic activated cell sorting (MACS)
seems to be able to remove spermatozoa with PS externalization and
to reduce the proportion of sperms having apoptotic features, including
DNA fragmentation (Said et al., 2005, 2006;Grunewald et al., 2006; Aziz
et al., 2007; Lee et al., 2010; Rawe et al., 2010; Degheidy et al., 2014;
Nadalini et al., 2014;Vendrell et al., 2014; Bucar et al., 2015). By this tech-
nique, the apoptotic cells are magnetically labeled with annexin
V-conjugated microbeads and pass through a MACS column placed in
the magnetic ﬁeld of a MACS separator. The PS-exposing cells, conju-
gated with the magnetic microbeads, are retained on the column,
while the unlabeled, non-apoptotic spermatozoa can pass through (Mil-
tenyi et al., 1990; Paasch et al., 2003). Two prospective randomized
studies have evaluated the effectiveness of annexin V–MACS sperm
sorting associated with density gradient centrifugation compared with
density gradient centrifugation alone in terms of ICSI outcomes,
with controversial results (Table VII). Dirican et al. (2008b) reported
increased cleavage and chemical pregnancy rates in the study group com-
pared with controls while implantation rate was of borderline statistical
signiﬁcance. Others authors have demonstrated an improved fertiliza-
tion rate and embryo quality but similar pregnancy and live birth rates.
Fifteen healthy babies born were reported (Sheikhi et al., 2013).
Interestingly, Dirican et al. (2008b) performed a gradient centrifugation
onlyafter theMACStechnique inorder toavoid the removalofcapacitated
normal spermatozoa. Indeed, albumin can stimulate capacitation and
some studies showed that PS externalization would be not only a sign of
early apoptosis but also may occur following capacitation (Kotwicka
et al., 2002; Grunewald et al., 2006; Salicioni et al., 2007). However, it
has to be underlined that both studies did not investigate apoptosis in
spermatozoa and no comparisonwasmade before and after themagnetic
cell separation.Threecasereportshavedescribedpregnancyachievement
and three healthy babies born after sperm sorting with annexin V–MACS
(PolakdeFried andDenady, 2010;Rawe et al., 2010;Herrero et al., 2013).
Some concern about the safety of this technique was raised regarding
the possibility for microbeads to remain on the surface of the non-
apoptotic spermatozoa used for ICSI. Based on experiments with trans-
mission electron microscopy, this event would be unlikely (Paasch et al.,
2003), although prospective studies are needed to establish the safety of
this strategy.
Improvement of the sperm sample before ICSI procedure: zeta potential
selection. An alternative method to select sperm prior to ICSI is the
zeta potential procedure (Table VII).
Since it has been demonstrated that amature spermpossesses a static
surface electrical charge of 216 to 220 mV (Focarelli et al., 2009),
named zeta potential, it has been proposed to exploit this characteristic
for sperm selection. This method is simple and inexpensive and it was
published for the ﬁrst time by Chan et al. (2006): the electrostatic
surface to immobilize the charged sperm is generated by simply placing
a glass centrifuge tube inside a latex glove and rotating the tube two or
three times. An incubation of 1 min at room temperature allows the ad-
herence of the charged sperm to the tubewall and a short centrifugation
is used towash away spermwith less charge. Adhering spermatozoa can
be detached from the tube surface by pipetting a serum-supplemented
medium in order to neutralize the tube charge (Chan et al., 2006).
Sperm cells isolated with this procedure have high DNA integrity and
low histone content (Chan et al., 2006), making the zeta potential
method an effective procedure for sperm selection. Moreover, several
researchers highlighted that the zeta method was able to select a
higher percentage of spermatozoa with intact DNA, in comparison
with the hyaluronic acid binding (Razavi et al., 2010). However, only
one prospective randomized study analyzed ICSI outcomes when zeta
sperm selection was applied (Kheirollahi-Kouhestani et al., 2009): in
this study, 30 couples agreed to have half of their oocytes inseminated
by sperms processed by the combined density gradient centrifugation/
zeta procedure, and half with density gradient centrifugation only. Fertil-
ization rate was improved following the combined density gradient
centrifugation/zeta procedure and it was shown that the selected
spermatozoa had less DNA fragmentation.
Improvement of the sperm sample before ICSI procedure: electrophoretic
separation. Electrophoretic systems for the rapid isolation of sperm exhi-
biting high levels of DNA integrity have been recently described. This
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TableVII Summaryof10papers identiﬁed inasystematic reviewof the literature inorder to investigate theeffectsofdifferent selectionmethodstomanagesperm
DNA fragmentation before ICSI on embryo development and clinical outcomes.
Sperm
sample
Notes FR Good EQ
rate
Cleavage
rate
BL
rate
CPR IR AbR LBR P/PR/R/
CR/CS
study
Before ICSI
procedure
MACS Dirican et al. (2008a, b) Ejaculated MACS versus
DGC
Unchanged Unchanged Improved — Improved Unchanged — — PR
Rawe et al. (2010) Ejaculated MACS selection — — — — — — One live
birth
CR
Polak de Fried and
Denaday (2010)
Ejaculated MACS selection — — — — Twin ongoing
pregnancies
— — CS
Sheikhi et al. (2013) Ejaculated MACS versus
DGC
Improved Improved Unchanged — Unchanged Unchanged — Unchanged PR
Herrero et al. (2013) Ejaculated MACS selection — — — — — — — Twin live
births
CR
Zeta potential
method
Kheirollahi-Kouhestani
et al. (2009)
Ejaculated DGC versus
DGC-Zeta
Improved Unchanged Unchanged Unchanged Unchanged — PR
Electrophoretic
system
Ainsworth et al. (2007) Ejaculated — — — — — — — One live
birth
CR
Fleming et al. (2008) Ejaculated DGC versus
CS-10
Unchanged Unchanged Unchanged — — — — PR
During ICSI
procedure
HAB Nasr-Esfahani et al.
(2008a, b)
Ejaculated Routine sperm
selection versus
HAB selection
Improved Unchanged Unchanged — Unchanged Unchanged — PR
Parmegiani et al. (2010) Ejaculated HAB selection
versus PVP
selection
Unchanged Improved — — Unchanged Unchanged Unchanged Unchanged PR
Improved or decreased results are indicated only when statistically signiﬁcant.
MACS, magnetic cell sorting; DGC, density gradient centrifugation; CS-10, Cell Sorter-10; HAB, hyaluronic acid binding assay; PVP, polyvinylpyrrolidone.
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method is based on the principles that the highest quality spermatozoa
within the ejaculate carry the greatest net negative charge (Giuliani
et al., 2004; Ainsworth et al., 2005) and that they can be separated
from other electronegative cells, such as leucocytes and immature
germcells, becauseof their smaller size.Hence, the separation isobtained
by the application of an electric ﬁeld that forces the spermatozoa to pass
through a polycarbonated ﬁlter containing 5 mm pores (Ainsworth et al.,
2005). A case report has reported the ﬁrst human pregnancy obtained
by using this procedure in a couple suffering from long-term infertility asso-
ciated with extensive sperm DNA damage (Ainsworth et al., 2007).
However, the only published prospective randomized controlled clinical
trial designed to compare spermatozoa prepared using this technique
and spermatozoa prepared by density gradient centrifugation has demon-
stratedcomparableratesof fertilization, cleavageandhigh-qualityembryos
(Fleming et al., 2008). Fleming et al. reported also three normal deliveries
fromembryos derived fromelectrophoretically selected spermatozoa.Of
course, further proof of safety is necessary to validate thismethod.Oneof
the exciting prospects of thismethod is its potential application for the iso-
lationof spermatozoa exhibiting low levels ofDNAdamage fromcomplex
cellular mixtures such as testicular or epididymal biopsies.
Selection of sperm during ICSI procedure: hyaluronic acid binding.Hyaluronic
acid is present in the cumulus oophorus surrounding ovulated eggs.
Current models suggest that spermatozoa pave their way through the
cumulus by binding hyaluronic acid to a speciﬁc protein located in the
sperm head, PH20. On this basis, a hyaluronan-binding assay has been
developed, representing a suitable and reproducible laboratory test for
selecting good-quality spermatozoa able to bind hyaluronan through
speciﬁc receptors (Cayli et al., 2003; Huszar et al., 2003, 2007; Parme-
giani et al., 2010). Moreover, selection of hyaluronan-bound spermato-
zoa has been reported to signiﬁcantly decrease the percentage of
sperm showing apoptotic marker proteins (Sakkas, 2013). An accurate
analysis of all the contributions reporting on ART outcomes derived
from sperm selected by hyaluronic acid binding can be found elsewhere
(McDowell et al., 2014). We have included herein only the studies that
have addressed the efﬁcacy of spermatozoa selection by hyaluronan-
binding in reducing DNA fragmentation. Basically, two protocols are
used for the sperm selection: in the ﬁrst protocol, a drop of diluted hya-
luronic acid is allowed to dry on the bottom of an ICSI dish. Sperm cells
are selected according to their ability to bind the solid hyaluronic acid
attached to the bottom of the dish (Nasr-Esfahani et al., 2008b).
Ready-to-use dishes are also available (Parmegiani et al., 2012). In the
second protocol, a ready-to-use viscous medium containing hyaluronic
acid is used. A drop of sperm suspension is mixed with a drop of
medium containing the hyaluronic acid on the base of the ICSI dish,
spermatozoa bound to hyaluronic acid are slowed in the junction zone
of the droplets and are selected for ICSI (Parmegiani et al., 2012). In
both protocols, spermatozoa have to be prepared by means of
swim-up or density gradient before sperm selection by hyaluronic acid
can be applied. The effectiveness of this procedure on ICSI outcomes
has been investigated, according to our searching criteria, by two
prospective studies (Table VII). Nasr-Esfahani et al. (2008b) observed
a signiﬁcant inverse correlation between percentage of hyaluronic acid
binding and DNA fragmentation. Furthermore, when a hyaluronan-
binding procedurewas applied for sperm selection prior to ICSI, a signiﬁ-
cantly higher fertilization rate was observed, while pregnancy and im-
plantation rates remain unchanged. In a prospective randomized study,
Parmegiani et al. (2010) reported that hyaluronan-selected sperm cells
show a lower DNA fragmentation level and less nuclear abnormality in
comparison with PVP selection. Signiﬁcantly, improved embryo quality
and development after ICSI were also observed.
Overall, the evidence is insufﬁcient to recommend one speciﬁc
method of sperm selection in the case of absolute asthenozoospermia
or high sperm DNA fragmentation.
Indeed, a considerable number of studies reported in the section ‘ICSI
and male gametes’ were classiﬁed as case series or case reports. Few
studies were prospective and randomized, and in most of them, the
study group was not compared with standard ICSI as a control group
but with a different advanced sperm selection method. Results are dis-
cordant and important clinical outcomes, such as miscarriage and fetal
abnormalities, are lacking. No clear data on possible adverse effects of
these techniques have been reported.
Discussion
After decades of practice using IVF, the current strategy is represented
by the personalization of treatment. This strategy should lead to an im-
provement in patient compliance andbetter clinical practice. Individualiza-
tionof treatment is not new to the ﬁeld ofmedicine, although this concept
is relatively fresh in reproductive medicine. In clinics, the availability of
new markers of ovarian reserve, the improvement in methodology for
their measurement and the huge amount of clinical data have supported
the view that individualization in IVF is the way forward (La Marca and
Sumkara, 2014). In laboratory practice, this view is only emerging, al-
though, especially in centers performing many cycles, it is always difﬁcult
to abandonwell-establishedprotocols in order to solve speciﬁc problems.
This review has been prepared mostly with the idea to support embryol-
ogists in trying to offer to the couples the best treatment tailored to
their unique characteristics. We have detailed the current knowledge on
procedures to improve the use of oocyte without the zona pellucida, to
solve difﬁcult issues related to fertilization failure or oocyte degeneration,
to use round-headed spermatozoa and to improve selection of viable
sperm in the case of absolute asthenozoospermia or high fragmentation
rate (Fig. 5). In this context, this analysis might represent a platform
to favor a rethinking of established procedure modalities in the IVF
laboratory and to support the individualization of treatment.
On the other hand, two important issues may be deduced from this
analysis. The ﬁrst is represented by the safety concern. The list of tech-
niques and procedures that have been brought into the IVF clinic over
the last years is long and it continues to grow. The ideal paradigm for
the introduction of new procedures or technologies implies initially
their development in animals (Harper et al., 2012). Whether animal
studies are appropriate or not, research should then be performed on
human gametes or embryos donated for research and with an appropri-
ate risk assessment.Moreover, sufﬁciently powered RCTs need to show
that there is a clinical beneﬁt and that the technique is safe, with neonatal
follow-ups if appropriate. For certain procedures, such as PGD, RCTs
are not appropriate because it would be impossible to have a control
group but for procedures that claim to increase delivery rates, RCTs
are essential (Harper et al., 2012). All deliveries need to be followed
up to ensure that any risks are within an acceptable range. Considering
the number of different procedures and treatments described in this
review, the number of published RCTs is very few, thus supporting the
idea that the necessary research for the introduction of a novel
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procedure is often not conducted properly. In this regard, some con-
cerns have been raised recently for the introduction in the market of a
commercially available medium containing Calmicyn to largely eliminate
the possibility of fertilization failure (van Blerkom et al., 2015). The risk
here is that the strategy will be used not only for selected patients,
without obtaining the necessary information to establish its safety. This
deﬁciency emerges dramatically for several procedures evaluated in
this analysis and not only for oocytes defects. Impressively, we were
unable to ﬁnd a single study evaluating short- and long-term follow-up
of children born after using pentoxifylline-selected sperm for ICSI, not-
withstanding that several IVF centers worldwide are known to have
used or use the compound in daily practice.
Figure 5 Summary of the practices advisable for speciﬁc situations during ICSI. Limitations of every single procedure are discussed in the text. MI/MII:
metaphase I/II.
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This brings us to the second important point derived from this analysis.
Embryologists should be encouraged to set up well-conducted studies,
to validate the techniques used and to report their ﬁndings. One may
argue that since it takes years to do the necessary research and develop-
ment and obtain the results of RCTs, such an approach will dampen the
developmentof the ﬁeld but previous examples have shown that it is pos-
sible to introduce technology bringing no clinical beneﬁt or even adverse
effects (Gleicher et al., 2014). On the other hand, huge amounts of
potentially valuable data deriving from the performance of thousands
of cycle all over theworld using various laboratory approaches are prob-
ably never published. While ICSI introduction has probably not been
achieved by following the classical steps of looking for new technologies
to be applied to humans (Harper et al., 2012), it implies so many critical
phases potentially affecting epigenetic, genetic or chromosomal errors
that follow-up studies in the human embryo and pediatric follow-ups
areneeded for eachof them.Thus, embryologists should be also encour-
aged to share their follow-up data deriving from the various technical
approaches used.
Finally, for a complete understanding of the potential consequences of
the ICSI technique, the biological basis of each stepof the ICSI procedure
needs tobe provided to embryologists togetherwith their training on the
mechanical aspects of the injection. This is particularly important consid-
ering that some steps of the procedure, such as timing of the injection
after oocyte retrieval, have reached a high level of standardization
without a strong scientiﬁc literature supporting it.
We are aware not to have included in this work important issues such
as the sperm selection using ultra-high magniﬁcation (IMSI). However,
IMSI has already been the focus of important analyses and discussions
(Teixeira et al., 2013; Setti et al., 2014). Our aim was to focus on
aspects critical to embryologists but for which review contributions
were absent or limited.
Conclusions
This reviewprovides the current knowledge on somecontroversial tech-
nical aspects of the ICSI procedure in order to improve its efﬁcacy in spe-
ciﬁc contexts. The introduction of ICSI was a revolution in reproductive
medicine, but the technique was introduced into clinical practice with
minimal proof of safety. The reﬁnements of the technique based on
evidence-based medicine represent a priority for the future. Even
many years after its introduction, the improvements and technical devel-
opments in ICSI still lack sufﬁcient well-designed studies.
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